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1 General Introduction 
1.1 Development of the terminology and diagnostic criteria for 
primary progressive aphasia  
Progressive fluent and nonfluent language disorders associated with atrophy in left 
frontal, perisylvian, and temporal regions were first described by Pick, Sérieux, and 
Rosenfeld (Pick, 1892; 1904 available in translation by Girling and Berrios, 1994, 
1997; Rosenfeld, 1909; Sérieux, 1893). Pick (1892) described a woman who suffered 
from a social disorder characterized by disinhibition and poor insight and whose 
language abilities progressively deteriorated until she finally became mute. Sérieux 
(1893) provided the first case report of an isolated progressive language disorder by 
describing a patient with halting speech, but intact memory, visuospatial abilities, and 
social functioning. Rosenfeld provided an early description of a patient with word-
finding difficulties, including a striking loss of the names of objects, circumlocutions, 
and semantic paraphasic errors in spontaneous speech (Rosenfeld, 1909). A few 
decades later, more single cases with fluent and nonfluent aphasia were described 
(Holland, McBurney, Moossy, & Reinmuth, 1985; Tyrrell, Kartsounis, Frackowiak, 
Findley, & Rossor, 1991; Warrington, 1975). Selective impairment of semantic 
memory (component of long-term memory containing knowledge of objects, facts, 
and concepts as well as words and their meaning; Tulving, 1972, 1983) was first 
introduced by Warrington (1975) to describe three patients with cerebral atrophy 
presenting with progressive anomia (i.e., problems recalling words or names) and 
impaired word comprehension. 
Mesulam (1982) introduced slowly progressive aphasia without dementia as a 
syndrome that maintains relatively isolated aphasia until the terminal stages of the 
disease and is mainly associated with neurodegeneration in left perisylvian regions. 
Five years later, he renamed this syndrome into primary progressive aphasia (PPA; 
Mesulam, 1987). Snowden, Goulding, and Neary (1989) proposed to distinguish 
between three subtypes of PPA: fluent progressive aphasia, non-fluent progressive 
aphasia, and a mixed subtype. These authors furthermore introduced the term 
semantic dementia to designate fluent progressive aphasia characterized by a 
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progressive breakdown in language and visual perception due to loss of semantic 
information and circumscribed cerebral atrophy in the temporal lobes (Snowden et 
al., 1989). Hodges, Patterson, Oxbury, and Funnell (1992) provided a comprehensive 
characterization of five case reports suffering from semantic dementia, and 
Grossman et al. (1996) described extensively four case reports of progressive 
nonfluent aphasia. 
The Lund and Manchester Groups proposed the first general guidelines for the 
clinical diagnosis of frontotemporal dementia (FTD), mentioning PPA by referring the 
reader to single case studies for a more detailed description of PPA (Brun et al., 
1994; Neary, Snowden, & Mann, 1993a, 1993b; Snowden, Neary, Mann, Goulding, & 
Testa, 1992). A consensus on more specific clinical and research diagnostic criteria 
for PPA was reached in 1998 (Neary et al., 1998). Here, the core diagnostic features 
for progressive nonfluent aphasia encompassed the insidious onset and gradual 
progression of the disease as well as nonfluent spontaneous speech with 
agrammatism, phonemic paraphasias, and/or anomia. The core diagnostic criteria for 
semantic dementia, on the other hand, included the insidious onset and gradual 
progression of the disease, progressive fluent empty spontaneous speech, loss of 
word meaning which becomes manifest by impaired naming and comprehension, 
semantic paraphasias and/or a perceptual disorder characterized by prosopagnosia 
(i.e., impaired recognition of identity of familiar faces) and/or associative agnosia (i.e., 
impaired recognition of object identity). Perceptual matching and drawing 
reproduction, preserved single-word repetition, and ability to read aloud and write to 
dictation orthographically regular words were assumed to be preserved in patients 
suffering from semantic dementia (Neary et al., 1998). In 2001, an international group 
of clinical and basic scientists reassessed the clinical criteria for FTD and proposed 
that a part of the patients suffering from FTD could be characterized by an early 
progressive change in language, characterized by problems with expression of 
language or severe naming difficulties and problems with word meaning (McKhann et 
al., 2001). 
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At the same time, Mesulam (2001) proposed to define PPA as a disease starting with 
anomia that progresses either into a) nonfluent language with phonemic paraphasia 
associated with atrophy and hypometabolism within left frontal and perisylvian 
atrophy or b) semantic memory loss associated with atrophy and hypometabolism 
within the left temporal lobe (Abe, Ukita, & Yanagihara, 1997; Mesulam, 2001). 
Mesulam (2001) furthermore proposed that language impairments should be the 
most important symptoms for at least two years and to refine the use of semantic 
dementia that had originally been adopted for patients showing a combination of 
verbal and visual processing deficits (e.g., Neary et al., 1998) to patients without 
visual processing deficits. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Timeline of the development of the terminology and diagnostic criteria for primary 
progressive aphasia. 
For two decades, researchers and clinicians have been using the diagnostic criteria 
for FTD (Brun et al., 1994; McKhann et al., 2001) to generally diagnose a patient as 
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suffering from PPA and the criteria of Neary et al. (1998) to further specify the 
diagnosis as progressive nonfluent aphasia or semantic dementia. However, there 
were a number of PPA cases that could not be classified according to the criteria of 
Neary and colleagues (Gorno-Tempini et al., 2004; Grossman & Ash, 2004; Neary et 
al., 1998). Given that many of these unclassifiable cases of PPA showed a similar 
pattern of symptoms, Gorno-Tempini et al. (2004) proposed to introduce a third 
subtype for PPA named logopenic progressive aphasia or logopenic variant PPA. 
Logopenic variant PPA is mainly characterized by impaired single-word retrieval in 
spontaneous speech and naming, impaired repetition of sentences and phrases, 
phonologic errors in spontaneous speech and naming, spared single-word 
comprehension and object knowledge, spared motor speech, and absence of frank 
agrammatism (Gorno-Tempini et al., 2008; Gorno-Tempini et al., 2004). In response 
to these new insights into PPA, an international consortium proposed new diagnostic 
clinical and research criteria in 2011 (Gorno-Tempini et al., 2011). The chronological 
development of the terminology and diagnostic criteria for PPA are shown in Figure 
1. 
According to the revised diagnostic clinical and research criteria (Gorno-Tempini et 
al., 2011), a patient first needs to meet the basic criteria for PPA in general (i.e., 
prominent, isolated language disorder during the initial phase of the disease) as 
proposed by Mesulam in 2001. Thereafter, the patient can be further diagnosed more 
specifically as suffering from one of the three subtypes of PPA. In order to 
standardize the terminology for PPA, it has been proposed to use the terms 
nonfluent/agrammatic variant PPA (nfvPPA), semantic variant PPA (svPPA), and 
logopenic variant PPA (lvPPA). In the following, we will apply this terminology. Note 
that the abbreviated form nonfluent variant PPA instead of nonfluent/agrammatic 
variant PPA will be used to increase the readability. The current diagnosis of the 
variants of PPA is threefold, designating the probability of the diagnosis: clinical 
diagnosis, imaging-supported diagnosis, and diagnosis with definite pathology 
(Gorno-Tempini et al., 2011; see Table 1). 
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The current diagnostic criteria for PPA variants with definite pathology are relatively 
unspecific because there is no straightforward correspondence between any variant 
of PPA and a given pathology (Gorno-Tempini et al., 2011). In most cases, the 
pathology is either FTLD (predominantly FTLD-TDP or FTLD-tau) or an atypical form 
of Alzheimer’s disease (AD; Gorno-Tempini et al., 2011; Grossman, 2014; Mesulam 
et al., 2014). FTLD-TDP refers to an accumulation in central nervous system neurons 
of transactive response DNA-binding protein of ~ 43kD, known as TDP-43 and FTLD-
tau refers to an accumulation of the microtubule-associated protein tau (MAPT) in 
neurons and glia (Grossman, 2014). FTLD pathology can arise either sporadically 
(most cases) or autosomal dominantly inherited with mutations most commonly in the 
progranulin (GRN) gene (associated with FTLD-TDP pathology), the MAPT gene 
(associated with FTLD-tau pathology), or the chromosome 9 open reading frame 72 
(C9orf72) gene (associated with FTLD-TDP pathology; Grossman, 2014). Regardless 
whether sporadic or autosomal dominantly inherited, studies on clinical-pathologic 
correlations in PPA suggest that nfvPPA might be rather related to tau-positive 
pathology, while svPPA might be rather related to TDP-43-positive pathology 
(Josephs et al., 2006; Mesulam et al., 2014; Mesulam et al., 2008). LvPPA has been 
proposed to be rather related to AD pathology (Mesulam et al., 2014; Mesulam et al., 
2008; Rabinovici et al., 2008). However, there is no one-to-one correspondence 
between a PPA variant and a given pathology as each PPA variant has been related 
to several different pathologies (Gorno-Tempini et al., 2011; Mesulam et al., 2014). 
1.2 Risk factors for primary progressive aphasia 
Identical underlying pathology can thus lead to different syndromes (e.g., AD, PPA or 
bvFTD; Gorno-Tempini et al., 2011; Mesulam et al., 2014). It has been proposed that 
there might exist susceptibility factors that interact with the neurodegenerative 
disease to determine its primary anatomical location (Rogalski, Weintraub, & 
Mesulam, 2013). Except for a high prevalence of learning disabilities (especially 
dyslexia) in the personal history of PPA patients (regardless of the underlying 
pathology or PPA variant) or in the history of their first-degree relatives, there is 
however little evidence for the existence of susceptibility factors until now (Rogalski 
et al., 2013). One study showed that vasectomy rates were significantly higher in 
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PPA patients (40 %) as compared to healthy controls (16 %) (Weintraub et al., 2006). 
Weintraub et al. (2006) speculated that vasectomy might induce an immune 
response to sperm, akin to paraneoplastic encephalitis, which somehow interacts 
with the primary neurodegenerative disease to make the language network the most 
important locus of neurosynaptic loss. However, there is currently no evidence of an 
overt immune-mediated neuropathology in PPA. Therefore, this suggestion remains 
highly speculative (Rogalski et al., 2013). 
1.3 Incidence and prevalence of primary progressive aphasia 
During the last decade, several population studies investigated the prevalence and 
incidence of FTD patients in Italy, the Netherlands, Spain, Finland, the United 
Kingdom, Canada, the United States, Australia, Korea, China, Japan, and India (Kim 
et al., 2014; Luukkainen, Bloigu, Moilanen, & Remes, 2015; Riedl, Mackenzie, Förstl, 
Kurz, & Diehl-Schmid, 2014; Withall, Draper, Seeher, & Brodaty, 2014). LvPPA is 
only rarely included in population studies on FTD, because this syndrome has rather 
been related to AD pathology (Mesulam et al., 2014; Mesulam et al., 2008; 
Rabinovici et al., 2008).  
The estimates for the prevalence of FTD range from 2/100,000 to 31/100,000 (Riedl 
et al., 2014). This wide variation is due to several reasons. Many population studies 
report point prevalence estimates, while some studies report (cumulative) period 
prevalence estimates. Another reason is that different studies considered different 
age ranges and partly also different diagnostic criteria (Riedl et al., 2014). 
Unfortunately, most population studies report prevalence and/or incidence estimates 
across FTD syndromes and there are only a few studies which actually included PPA 
patients. In studies, where PPA patients were included, the estimated point 
prevalence of FTD is estimated at 15-22 per 100,000 in the population between 45 
and 65 years (Borroni et al., 2015; Harvey, Skelton-Robinson, & Rossor, 2003; 
Knopman & Roberts, 2011; Onyike & Diehl-Schmid, 2013; Ratnavalli, Brayne, 
Dawson, & Hodges, 2002; Riedl et al., 2014). This point prevalence corresponds 
approximately to the prevalence of AD in this age group (Onyike & Diehl-Schmid, 
2013; Riedl et al., 2014). The incidence for FTD (including PPA patients) estimates 
 1. General Introduction 
15 
 
for this age group ranged from 2.7-4.1 per 100,000 in the population (Onyike & Diehl-
Schmid, 2013). 
Until now, there are however no community-based prevalence and incidence 
estimates for the three PPA variants available (Grossman, 2014). Based on autopsy-
proven cases, however, it has been estimated that about 40 % of the patients with 
FTLD pathology have PPA (Grossman, 2014). BvFTD is thus almost three to four 
times as common as one of the three PPA variants (Hogan et al., 2016; Knopman & 
Roberts, 2011). This suggests a prevalence for PPA of 1.1-6.0 per 100,000 in the 
population with FTLD pathology and additional cases with AD pathology (Grossman, 
2014). The estimated incidence for PPA is approximately 0.88-1.4 per 100,000 in the 
population with FTLD pathology. Men and women seem to be equally affected 
(Hogan et al., 2016; Riedl et al., 2014) and the mean age of onset is approximately 
58 years with later peak ages at initial diagnosis for nfvPPA (70-79 years; Coyle-
Gilchrist et al., 2016; Grossman, 2014; Riedl et al., 2014). The survival time after 
initial diagnosis varies between 3-14 years with svPPA patients surviving a little bit 
longer (median of 12 years) than nfvPPA (median of 9 years). For lvPPA, there are 
currently no data on gender distribution, age at initial diagnosis and average survival 
time available. Due to its rareness, PPA has been declared an orphan disease 
(Orpha number ORPHA282, http://www.orpha.net). 
1.4 German and Italian Consortium of Frontotemporal Lobar 
Degeneration 
In order to gain more insight into prevalence and incidence estimates of the different 
clinical syndromes of frontotemporal lobar degeneration (FTLD), several national and 
international consortia have been established during the last years. Examples include 
the Italian FTD Network under the aegis of the Italian Neurological Society for 
Dementia (SINDEM) which includes 85 study centers (Borroni et al., 2015), the 
longitudinal study on FTD of the Clinical Research Center for Dementia of South 
Korea including 16 centers (Kim et al., 2014), or the German and Italian Research 
Consortium of FTLD (Otto et al., 2011).  
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The German and Italian Research Consortium of FTLD encompasses currently 12 
centers in Germany (see Figure 2) and 11 centers in Italy (www.ftld.de). All centers 
use a common study protocol involving medical assessment, neuropsychological and 
language assessment, MRI (and PET if available) scanning, as well as blood 
sampling. All instructions and materials are available in German and Italian language. 
The aims of this consortium besides collecting data on epidemiology, are to improve 
disease recognition along with its management, monitor disease progression, find 
early disease markers and to develop and evaluate possible therapeutic approaches 
(Otto et al., 2011) 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Sites of the German study centers involved in the German and Italian Research Consortium 
for Frontotemporal Lobar Degeneration (modified from http://www.ftld.de). 
1.5 Therapeutic approaches for primary progressive aphasia 
There are a few studies that report minor improvements of confrontation naming 
immediately following speech therapy on word-finding abilities in patients with PPA 
and two studies reported successful short-term outcomes of treatment of written 
language (Riedl et al., 2014; Tippett, Hillis, & Tsapkini, 2015). A few studies also 
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showed short-term improvement of language abilities when repetitive transcranial 
magnetic stimulation or transcranial direct current stimulation was applied while 
participants were performing a language task. Note however that most intervention 
studies were case reports or included only a small number of participants (Tippett et 
al., 2015) and that there is no evidence for the sustainability and generalizability of 
any of these treatments (Riedl et al., 2014; Tippett et al., 2015). Symptoms in lvPPA 
might be reduced with medications that have been shown to reduce or delay the 
progression of symptoms in AD (acetylcholinesterase inhibitors as donepezil, 
rivastigmine, or galantamine and/or N-Methyl-D-Aspartat glutamate receptor 
antagonists as memantine) as most lvPPA patients show underlying AD pathology 
(see section 1.1). This assumption needs however still to be empirically supported by 
large-scale randomized clinical trials (Otto et al., 2011; Tippett et al., 2015). Selective 
serotonin reuptake inhibitors such as citalopram or sertraline have been shown to 
reduce behavioral disturbances such as obsessive-compulsive behavior, 
restlessness, eating disorders or disinhibition (Manoochehri & Huey, 2012). 
Therefore, clinicians are currently advised to prescribe selective serotonin reuptake 
inhibitors to PPA patients who show additionally symptoms that are rather 
prototypical for bvFTD (Manoochehri & Huey, 2012; Otto et al., 2011). All in all, there 
are currently no recommended medications for the treatment of PPA symptoms. 
1.6 Neuroimaging 
1.6.1 Positron emission tomography 
In positron emission tomography (PET), the patient receives an intravenous injection 
of a radiotracer that emits a positron (Berns, 1999; Small et al., 2008). When the 
positron encounters an electron, they annihilate each other and their collective 
energy is transformed into two gamma photons that are emitted in opposite directions 
and can be recorded by detectors that are 180° apart from each other. PET scanners 
are equipped with a ring of detectors that determine the line along which the 
annihilation occurs in order to reconstruct the 3D localization of the physiological 
process of interest with a spatial resolution of 3-5 mm. A physiological process that is 
often measured using PET is local glucose metabolism which changes in response to 
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synaptic activity and depends on cell density. PET is thus well suited to detect 
neurodegenerative diseases and monitor their disease progression. The most 
common radioactive tracer used to measure local glucose metabolism in the brain is 
fluoro-deoxyglucose (18FDG) which leads to the general use of the term FDG-PET to 
designate this neuroimaging method (Berns, 1999; Small et al., 2008). 
1.6.2 Structural magnetic resonance imaging  
Another neuroimaging method that is well suited to detect neurodegenerative 
diseases and monitor their progression is structural MRI. Structural MRI has some 
advantages over FDG-PET: it does not require the injection of a radioactive tracer 
(and is thus not invasive) and it provides images with a high resolution of ~1 mm 
(e.g., Berns, 1999).  
The magnetic resonance imaging technique is based on an intrinsic property of 
hydrogen protons, namely their spin (Berns, 1999; Small et al., 2008). Normally, the 
spin axes are oriented randomly, but when a strong external magnetic field (e.g., MRI 
scanner) is applied, the axes align themselves in the direction of that field. This leads 
to a measurable magnetization along the scanner magnet. The time to reach this 
magnetization is called T1. Similar to a spinning top, the single hydrogen protons do 
not spin exactly along a single axis, but instead, there is a slow wobble called 
precession. In MRI, after the hydrogen protons’ spins are aligned, a radiofrequency 
pulse at the precession frequency of the hydrogen protons is applied to knock the 
precession axis out of its original orientation. If enough protons get bumped, the 
tissue acquires a slight magnetization perpendicular to the external field which is 
called transverse magnetization. After switching off the radiofrequency pulse, the 
transverse magnetization decays. Different processes reflect the decay of the 
induced transverse magnetization, called T1-, T2- and T2*-relaxation. The duration of 
these different relaxation processes depends on the molecular environment of the 
protons, which allows differentiating between grey matter, white matter, and 
cerebrospinal fluid. By repeating the process of excitation and relaxation several 
times and varying the magnetic field gradients, 3D images of the brain can be 
encoded and reconstructed. 
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Before structural 3D images of the brain (acquired using PET or MRI) can be used in 
group-level analyses, they need to be preprocessed which includes realignment of 
the single slices, coregistration and normalization to a standard brain template, and 
segmentation of the different tissue types (grey matter, white matter, and 
cerebrospinal fluid) as well as smoothing by a Gaussian kernel (e.g., Ashburner & 
Friston, 2000, see section 3.2.3.2). 
1.7 Aim of this thesis 
For two decades, researchers and clinicians have been using the diagnostic criteria 
for FTD (Brun et al., 1994; McKhann et al., 2001) to generally diagnose a patient as 
suffering from PPA and the criteria of Neary et al. (1998) to further specify the 
diagnosis as progressive nonfluent aphasia or semantic dementia. However, there 
were a number of PPA cases that could not be classified according to the criteria of 
Neary and colleagues (Gorno-Tempini et al., 2004; Grossman & Ash, 2004; Neary et 
al., 1998), which led to a revision of the diagnostic clinical and research criteria for 
PPA (Gorno-Tempini et al., 2011). The revised criteria encompass three PPA 
variants (svPPA, nfvPPA, and lvPPA) with three stages characterized by increasing 
evidence: clinical diagnosis, imaging-supported diagnosis, and diagnosis with definite 
pathology. As compared to the previous diagnostic criteria, more emphasis is placed 
on imaging markers as supportive features. These imaging criteria were however 
proposed based on a purely qualitative evaluation of the literature and have not been 
validated so far. 
The aim of this thesis was to evaluate the validity of the new diagnostic imaging 
criteria for PPA variants (first study) and to investigate the usefulness of these 
imaging criteria for the individual diagnosis of PPA patients in clinical routine (second 
study). 
In the first study (Bisenius et al., 2016), we raised the question whether the proposed 
diagnostic imaging criteria indeed represent subtype-specific prototypical atrophic 
networks for PPA variants (chapter 2). In order to address this question, we provided 
a quantitative evaluation (meta-analyses) of all currently available imaging studies on 
PPA. We hypothesized to find specific atrophic networks for each of the PPA variants 
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that are in line with the current diagnostic imaging criteria. Furthermore, we raised the 
question whether the proposed imaging criteria apply similarly to different imaging 
modalities (MRI and PET) as suggested in the current diagnostic criteria for PPA 
(Gorno-Tempini et al., 2011). Given that for other types of dementia (e.g., AD and 
bvFTD), separate diagnostic imaging criteria have been proposed for MRI and PET 
scans (Dubois et al., 2007; Schroeter et al., 2014), we hypothesized that separate 
imaging modality-specific criteria might also apply for PPA. 
In the second study (Bisenius et al., 2017), we first addressed the question whether 
(whole brain) structural MRI scans provide indeed useful information for the correct 
individual diagnosis of PPA patients (chapter 3). We were also interested in finding 
out which brain regions would be the most indicative for the correct diagnosis of PPA 
patients. We hypothesized that, when considering the whole brain MRI scan, the 
most important brain regions for the correct individual diagnosis of PPA patients 
would correspond to brain regions that are largely atrophied in these patients. In a 
second step, we raised the question whether focusing exclusively on the prototypical 
atrophic networks for PPA revealed by the meta-analyses reported in the first study, 
would enhance the diagnostic value of MRI scans for the correct diagnosis of PPA 
patients. These prototypical atrophic networks constitute in a sense a quantification 
of the current imaging criteria for PPA. Therefore, we hypothesized that considering 
only these prototypical atrophic networks would further enhance the diagnostic value 
of MRI scans (and thus provide empirical support for the usefulness of the proposed 
diagnostic imaging criteria for PPA in clinical routine). 
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2 Validating New Diagnostic Imaging Criteria for     
Primary Progressive Aphasia via ALE Meta-
Analyses 
2.1 Introduction 
Primary progressive aphasia (PPA) subsumes three gradually progressive language 
disorders, namely its semantic variant (svPPA) or semantic dementia, the nonfluent 
variant (nfvPPA) or progressive nonfluent aphasia, and the logopenic variant (lvPPA) 
or logopenic progressive aphasia (Gorno-Tempini et al., 2008; Gorno-Tempini et al., 
2004; Gorno-Tempini et al., 2011; Mesulam, 1982; Neary et al., 1998). Recently, an 
international consortium has refined the diagnostic clinical and imaging criteria for 
PPA variants (Gorno-Tempini et al., 2011). The imaging criteria include changes of 
structure, metabolism or perfusion in the anterior (ventral and lateral) temporal lobe 
for svPPA, in left posterior fronto-insular regions (inferior frontal gyrus, insula, 
premotor, and supplementary motor areas) for nfvPPA, and in left posterior 
perisylvian or parietal areas (posterior parietal, supramarginal, and angular gyri) for 
lvPPA (Gorno-Tempini et al., 2011). 
Here, we used anatomical likelihood estimation (ALE) meta-analyses to validate the 
current imaging criteria with higher statistical power than can be provided by single 
studies (Chein, Fissell, Jacobs, & Fiez, 2002; Turkeltaub, Eden, Jones, & Zeffiro, 
2002). ALE meta-analyses have been applied to investigate neurodegenerative 
diseases like mild cognitive impairment, AD, or FTD (Schroeter, Raczka, Neumann, 
& von Cramon, 2008; Schroeter, Stein, Maslowski, & Neumann, 2009; Yang, Pan, 
Song, Huang, et al., 2012; Yang, Pan, Song, & Shang, 2012). We wanted to identify 
the neural networks affected in the three PPA variants and examine their regional 
specificity in subtraction and conjunction analyses identifying specific and 
overlapping networks, respectively. It has been proposed that different diagnostic 
imaging criteria should be applied for AD and bvFTD to different imaging modalities – 
FDG-PET visualizing hypometabolism, MRI showing atrophy, and perfusion changes 
 2. Anatomical likelihood estimation meta-analyses on PPA 
22 
 
(Dubois et al., 2007; Schroeter et al., 2014). Accordingly, we hypothesized that the 
new diagnostic imaging criteria for PPA should be differentiated for MRI and PET. 
2.2 Materials and methods 
2.2.1 General study selection criteria 
The present work was done following the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) statement guidelines (Moher, Liberati, 
Tetzlaff, & Altman, 2010). PubMed was queried for abstracts published between 
January 1990/April 2012 containing following keywords: (primary progressive 
aphasia OR progressive nonfluent aphasia OR semantic dementia OR logopenic 
progressive aphasia) AND (positron emission tomography OR PET OR magnetic 
resonance imaging OR MRI). Following inclusion criteria were applied: peer-reviewed 
original studies, patients classified according to internationally recognized diagnostic 
criteria (Brun et al., 1994; Gorno-Tempini et al., 2011; McKhann et al., 2001; Neary et 
al., 1998), age-matched healthy controls, whole-brain analyses reporting 3D-
coordinates of atrophy/hypometabolism maxima in standardized stereotaxic space, 
Talairach atlas or Montreal Neurological Institute (MNI) templates. Studies reporting 
only regions-of-interest (ROI) analyses were excluded to avoid a potential publication 
bias. When studies fulfilled the inclusion criteria, but no coordinates were reported, 
authors were asked to provide coordinates. 
2.2.2 Anatomical likelihood estimation meta-analysis method 
ALE meta-analyses were computed within BrainMap Ginger ALE 2.1.1 (online at 
http://www.brainmap.org/ALE; Eickhoff, Bzdok, Laird, Kurth, & Fox, 2012; Eickhoff et 
al., 2009; Laird et al., 2005; Turkeltaub et al., 2002). Before data analysis, 
coordinates in Talairach space were converted into MNI coordinate space using the 
tal2icbm transform (Lancaster et al., 2007) except for one study (Perneczky, Diehl-
Schmid, Pohl, Drzezga, & Kurz, 2007) where we used the tal2mni transform (Brett, 
Johnsrude, & Owen, 2002) because these authors transformed data via mni2tal 
transform (Brett et al., 2002) into Talairach space. 
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In the ALE method, foci are modeled as 3D Gaussian probability distributions with 
variable full width at half maximum that takes into account between-subject and 
between-template variance (Eickhoff et al., 2009). We computed separate meta-
analyses for each of the three PPA variants at a false discovery rate (FDR) corrected 
significance level of p < 0.05. Cluster inference thresholds were chosen to exceed 
the number of voxels corresponding to 5 % possible false positives. 
We additionally computed subtraction analyses (Eickhoff et al., 2011) between the 
different meta-analyses on svPPA (MRI vs. PET) and the different variants of PPA. 
Here, the ALE maps (p < 0.05, FDR corrected) resulting from the separate meta-
analyses are subtracted from each other and compared against a null-distribution of 
differences in ALE scores (5000 permutations). The cluster inference threshold for 
the subtraction analyses was set to 200 mm3 (p < 0.05, uncorrected; Huang et al., 
2012). Conjunctions were assessed by a minimum statistic of images containing 
significant results from the individual meta-analyses (Nichols, Brett, Andersson, 
Wager, & Poline, 2005). 
2.3 Results 
2.3.1 Identified studies 
Out of 658 originally identified studies, 478 studies had to be excluded due to none-
relevant topics and 150 studies for specific reasons (see Supplementary Figure A). 
The final pool consisted of 30 studies (20 MRI, seven FDG-PET, three MRI & FDG-
PET) fulfilling the inclusion criteria. As some studies investigated more than one 
variant of PPA, the search resulted finally in 22 studies for semantic variant PPA (15 
MRI, six FDG-PET, one MRI & FDG-PET), 14 for nfvPPA (11 MRI, three FDG-PET), 
and six for lvPPA (six MRI, zero FDG-PET) including 396 patients. The one study on 
svPPA that reported both MRI and FDG-PET coordinates (Desgranges et al., 2007) 
was counted as one MRI and one FDG-PET study. Age, duration, and severity of 
disease as measured with the Mini-Mental State Examination did not differ between 
patients of the different PPA variants (Table 2). Detailed information for all included 
studies is available in the supplement (Supplementary Table A.1 and Supplementary 
References A). 
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Table 2 
Clinical characteristics of the patient groups 
Note. lvPPA logopenic variant PPA, MMSE Mini-Mental State Examination, MRI magnetic resonance 
imaging, nfvPPA nonfluent variant PPA, PET positron emission tomography, svPPA semantic variant 
PPA. Age, disease duration, and MMSE are indicated as mean±standard deviation. Age and disease 
duration are indicated in years. 
2.3.2 Separate meta-analyses for the different variants of primary progressive 
aphasia 
2.3.2.1 Semantic variant PPA 
MRI: As illustrated in dark green color in Figure 3 on the top, the meta-analysis on 
svPPA across the 16 MRI studies including 177 foci and 169 subjects yielded 
significant clusters of atrophy bilaterally in the inferior, middle, and superior temporal 
gyri, fusiform gyri, hippocampus, parahippocampal gyri, and right amygdala. Details 
on the respective MNI coordinates, cluster sizes, ALE values, and Brodmann Areas 
(Bas) are given in Table 3. 
FDG-PET: The meta-analysis on svPPA across the seven FDG-PET studies 
encompassed 36 foci and 70 subjects. As illustrated in light-green in Figure 3, 
second row, consistent hypometabolism was found bilaterally in the anterior inferior 
temporal gyri, the left fusiform gyrus, posterior midcingulate gyrus, corpus callosum, 
and left medial thalamus (for more details, see Table 3). 
 
 svPPA MRI svPPA PET nfvPPA MRI nfvPPA PET lvPPA MRI ANOVA (df, F, p) 
Number of 
studies/foci 
16/177 7/36 11/101 3/26 6/70 
 
Number of 
patients 
169 57 93 26 51 
 
Age  64.66 ± 2.91 64.29 ± 1.57 66.64 ± 2.32 67.90 ± 2.57 64.55 ± 4.47 (4,41), 1.32, 0.28 
Disease 
duration 
4.87 ± 1.64 3.82 ± 0.47 4.03 ± 1.22 3.30 ± 0.14 3.73 ± 1.30 (4,31), 1.86, 0.14 
MMSE 23.12 ± 2.18 23.10 ± 2.51 23.20 ± 3.44 21.34 ± 2.15 21.38 ± 1.15 (4,39), 0.89, 0.48 
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Figure 3: Results of the anatomical likelihood estimation (ALE) meta-analyses for each of the different 
variants of primary progressive aphasia. Atrophy was measured with magnetic resonance imaging 
(MRI), glucose hypometabolism with fluorodeoxyglucose positron emission tomography (PET). 
Logopenic variant PPA (lvPPA), nonfluent variant PPA (nfvPPA), semantic variant PPA (svPPA). 
False discovery rate (FDR) corrected p < 0.05. Left side is left. 
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Table 3 
 Results of the anatomical likelihood estimation meta-analyses on semantic variant PPA, nonfluent 
variant PPA, and logopenic variant PPA 
 
Note. ALE anatomical likelihood estimation, Bas Brodmann areas, FDG-PET fluorodeoxyglucose 
positron emission tomography, Lat. Lateralization, L left, lvPPA logopenic variant PPA, MNI Montreal 
Neurological Institute, MRI magnetic resonance imaging, nfvPPA nonfluent variant PPA, R right, 
svPPA semantic variant PPA. 
 
 
Region Lat. Bas                  MNI 
coordinates 
Volume ALE 
             x         y       z   (mm3)  
svPPA MRI         
Inferior, middle, & superior temporal 
gyri/fusiform gyrus/hippocampus/ 
R 20/21/ 24 0 -22 11312   0.0202 
parahippocampal gyrus/amygdala  36/38       
Hippocampus/parahippocampal 
gyrus/fusiform gyrus 
L 36 -26 -12 -16 6744   0.0235 
Superior temporal gyrus L 38 -38 16 -28 2568   0.0172 
Inferior & middle temporal gyrus L 21/38 -46 2 -44 1552   0.0167 
Fusiform gyrus L 20 -44 -32 -24 1536   0.0227 
svPPA PET         
Inferior temporal gyrus/fusiform gyrus L 20/21 -38 -12 -34 1976    0.0127 
Inferior temporal gyrus L 20 -48 -26 -30 520   0.0108 
Inferior temporal gyrus R 20 42 -2 -42 448   0.0076 
Inferior temporal gyrus L 38 -40 2 -46 424   0.0106 
Posterior midcingulate gyrus/corpus 
callosum 
L 24 -10 6 26 424   0.0083 
Thalamus  L  -6 -20 14 376   0.0080 
nfvPPA MRI         
Insula/inferior frontal gyrus L 13 -44 12 2 1360  0.0107 
Middle & superior temporal gyri L 21 -62 -58 6 624  0.0109 
Inferior & middle frontal gyrus L 9/10 -34 46 20 552  0.0097 
Inferior frontal gyrus L  -48 16 24 544  0.0131 
Superior frontal gyrus  L 6 -22 -4 64 448  0.0102 
Putamen L  -22 10 -6 424  0.0110 
Middle frontal gyrus/precentral gyrus L 6 -42 2 50 424  0.0115 
nfvPPA PET         
Superior temporal gyrus L 21 -62 -14 -16 744  0.0089 
Insula/inferior frontal gyrus, pars opercularis L 13 -46 12 -6 160  0.0067 
Lateral orbital gyrus L 46 -50 46 -2 160  0.0073 
Middle temporal gyrus L  -50 -28 -12 88  0.0068 
Nucleus caudatus  R  10 6 4 88  0.0068 
Thalamus L  -2 -22 6 88  0.0068 
Nucleus caudatus L 22 -10 2 6 88  0.0068 
Middle frontal gyrus L 9 -52 28 28 88  0.0068 
lvPPA MRI         
Middle & superior temporal gyri/parallel 
sulcus 
L 22/41 -54 -38 14 3344  0.0120 
Supramarginal gyrus L 39/40 -54 -54 32 2184  0.0136 
Superior temporal gyrus  L 21 -66 -22 -4 1192  0.0135 
Dorsal posterior cingulate gyrus L 23 0 -32 28 488  0.0117 
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MRI & FDG-PET: The results of both imaging meta-analyses on svPPA were 
projected together onto the same MNI template, which revealed only small 
conjunctions between MRI and FDG-PET studies in the left inferior and middle 
temporal gyrus (see Figure 4 on the top). To validate the specificity between imaging 
modalities, we conducted additionally subtraction analyses between both meta-
analyses on svPPA. As shown in Figure 4 in the middle upper part, right inferior, 
middle and superior temporal gyri, right fusiform gyrus, and bilateral 
hippocampus/parahippocampal gyri/amygdalae were specifically related to atrophy 
as measured with MRI, while left thalamus and left inferior temporal gyrus/fusiform 
gyrus were more specifically related to hypometabolism as measured by FDG-PET. 
A detailed overview is given in Supplementary Table A.2. 
2.3.2.2 Progressive nonfluent aphasia 
MRI: An overview of the results for nfvPPA is given in Table 3 and the relevant 
clusters are depicted in red in Figure 3, third row. The meta-analysis on nfvPPA 
across the 11 MRI studies (101 foci, 90 subjects) revealed clusters of significant 
atrophy solely in the left hemisphere, in particular in the putamen, anterior and middle 
insula, inferior, middle, and superior frontal gyri, as well as middle and superior 
temporal gyri. This result was in essence replicated in an analysis including only the 
seven studies that explicitly excluded subjects with lvPPA. 
FDG-PET: As illustrated in orange color in Figure 4, fourth row, the meta-analysis on 
nfvPPA across the three PET studies including 26 foci and 26 subjects yielded 
significant clusters of hypometabolism bilaterally in the caudate nuclei as well as in 
the left hemisphere in the thalamus, middle and superior temporal gyri, insula/inferior 
frontal gyrus, pars opercularis, lateral orbital gyrus, and middle frontal gyrus.  
MRI & FDG-PET: The results of both imaging meta-analyses on nfvPPA were 
projected together onto the same MNI template to visualize possible conjunct atrophy 
and hypometabolism to identify common networks. As shown in Figure 4 on the 
bottom, the results of both meta-analyses were disjunct. Note however that due to 
the small number of studies in the meta-analysis on nfvPPA across PET studies, no 
subtraction analysis was performed. 
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Figure 4: Comparison between the anatomical likelihood estimation (ALE) meta-analyses across 
different imaging modalities for semantic variant PPA (svPPA) and nonfluent variant PPA (nfvPPA) to 
identify method-specific and -common neural networks. Conjunction/overlap between atrophy 
(magnetic resonance imaging, MRI), and glucose hypometabolism (fluorodeoxyglucose positron 
emission tomography, PET) (A) in svPPA, and (C) in nfvPPA. (B) Results of the subtraction analysis 
between both meta-analyses on svPPA. False discovery rate (FDR) corrected p < 0.05. Left side is 
left. 
2.3.2.3 Logopenic progressive aphasia 
MRI: As illustrated in blue color in Figure 3 on the bottom, the meta-analysis on 
lvPPA (6 MRI studies) encompassing 70 foci and 58 subjects yielded significant 
clusters of atrophy exclusively in the left hemisphere in middle and superior temporal 
gyri, parallel sulcus, supramarginal gyrus, superior temporal gyrus, and dorsal 
posterior cingulate gyrus. The respective MNI coordinates, cluster sizes, ALE values 
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and Bas are shown in Table 3. For FDG-PET, we did not find any study in the 
literature investigating lvPPA. 
Figure 5: Comparison between the meta-analyses on the different variants of primary progressive 
aphasia for atrophy as measured with magnetic resonance imaging (MRI). (A) Conjunction/overlap 
between semantic variant PPA (svPPA), nonfluent variant PPA (nfvPPA), and logopenic variant PPA 
(lvPPA). (B) Results of the subtraction analyses to identify PPA variant-specific networks. False 
discovery rate (FDR) corrected p < 0.05. Left side is left. 
2.3.2.4 Comparison between the meta-analyses on the different variants of 
  primary progressive aphasia 
The results of the three MRI meta-analyses on the different variants of PPA were 
projected together onto an MNI template to investigate the variant-specificity. For 
FDG-PET such an analysis was not possible due to limited study numbers. As shown 
in Figure 5 at the top, there was no overlap between the results of the meta-analyses 
across MRI studies on svPPA (dark green), nfvPPA (red), and lvPPA (blue), except 
for a small conjunction (64 mm3, purple) between nfvPPA and lvPPA in the left 
posterior middle temporal gyrus. To validate the regional specificity for each PPA 
variant, we conducted additionally subtraction analyses (nfvPPA > svPPA & lvPPA, 
svPPA > nfvPPA & lvPPA, lvPPA > svPPA & nfvPPA) between the meta-analyses on 
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the different PPA variants. The results of the subtraction analyses are shown in 
Figure 5 at the bottom and details on the respective MNI coordinates, cluster sizes, 
ALE values, and BAs are reported in Supplementary Table A.2. The analysis 
revealed that almost all atrophic brain regions as identified in the ALE meta-analysis 
for each PPA variant separately (see Figure 3) were also specific for this variant (see 
anatomical description above). 
2.4 Discussion 
The present work validated the recently proposed imaging criteria for the three 
variants of PPA using ALE meta-analyses. In the following, we will first focus on the 
results of the variant-specific meta-analyses. Thereafter, we will emphasize the 
distinctiveness of the networks of atrophy for svPPA, nfvPPA, and lvPPA and discuss 
future clinical implications of the relative disjunction between the meta-analyses on 
svPPA (and nfvPPA) across different imaging modalities. 
2.4.1 Validation and refinement of diagnostic imaging criteria for primary 
 progressive aphasia 
The new diagnostic imaging criteria for svPPA include anterior (ventral and lateral) 
temporal lobes (Gorno-Tempini et al., 2011). Our meta-analyses on svPPA across 
MRI studies confirmed atrophy bilateral in anterior ventral temporal lobe (inferior 
temporal gyrus) and anterior lateral temporal lobe (middle/superior temporal gyri, 
fusiform gyrus), but extended the proposed regions towards the anterior medial 
temporal lobe (right amygdala and bilaterally hippocampus/parahippocampal gyri). 
Similarly, the results of our meta-analysis on nfvPPA across MRI studies confirmed 
insula, inferior frontal gyrus, premotor (inferior, middle, and superior frontal gyrus), 
and supplementary motor areas (superior frontal gyrus) as useful diagnostic imaging 
criteria for nfvPPA (Gorno-Tempini et al., 2011). The results of our meta-analysis on 
nfvPPA across MRI studies additionally showed consistent atrophy in middle and 
superior temporal gyri, putamen, and precentral gyrus, thus emphasizing the role of 
these regions for the diagnosis of nfvPPA. 
The proposed imaging criteria for lvPPA encompass posterior perisylvian/parietal 
areas, supramarginal gyrus, and angular gyrus (Gorno-Tempini et al., 2011). The 
 2. Anatomical likelihood estimation meta-analyses on PPA 
31 
 
results of our meta-analysis on lvPPA support the supramarginal gyrus and posterior 
perisylvian regions (superior temporal gyrus), but not the angular gyrus as 
consistently atrophied regions across studies. Interestingly, our meta-analysis on 
lvPPA showed additionally atrophy in the dorsal posterior cingulate gyrus and in 
superior/middle temporal gyrus, thus highlighting the importance of these regions for 
future MRI based diagnosis of lvPPA. Furthermore, atrophy in the posterior cingulate 
cortex in lvPPA supports the assumption that lvPPA is pathologically closely related 
to AD (Rabinovici et al., 2008; Schroeter et al., 2009). Interestingly, the conjunction of 
the different meta-analyses across MRI studies showed a regional overlap in the 
posterior middle temporal gyrus between nfvPPA and lvPPA, which suggests that 
this region might play an important role in both PPA variants. However, given that 
this overlap was very small, a high clinical specificity and usability of the diagnostic 
imaging criteria for PPA variants is still guaranteed. This was further supported by the 
subtraction analysis identifying specific atrophic networks related to each PPA 
variant. 
Although the new diagnostic criteria contain also brain perfusion markers, we could 
not detect any studies with this imaging modality in PPA. Interestingly, recent studies 
for AD revealed regionally coinciding reductions in glucose metabolism and perfusion 
(e.g., Dubois et al., 2007). In analogy, we assume that changes of these imaging 
modalities coincide regionally in PPA variants as well, although this hypothesis has to 
be proofed by future meta-analyses. 
2.4.2 Open up the road to method-specific diagnostic imaging criteria for 
primary progressive aphasia 
Interestingly, there were only small conjunctions (in inferior and middle temporal 
gyrus) between the results of the meta-analysis on svPPA across MRI studies and 
the one across FDG-PET studies. The meta-analysis on svPPA across FDG-PET 
studies furthermore extended the relevant regions for this PPA variant towards limbic 
regions, in particular the posterior midcingulate gyrus, and the thalamus. This 
implicates on the one hand that the posterior midcingulate gyrus and thalamus might 
play a larger role as diagnostic imaging criteria for svPPA as formerly assumed. 
However, the specificity of these regions is hampered by the fact that comparable 
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meta-analyses have identified these regions as relevant for bvFTD and AD as well 
(Dubois et al., 2007; Schroeter et al., 2008). On the other hand, results suggest 
different diagnostic imaging criteria for FDG-PET than for MRI as has already been 
proposed for bvFTD and AD (Dubois et al., 2007; Schroeter et al., 2014; Schroeter et 
al., 2008). There was no overlap between the meta-analysis on nfvPPA across MRI 
studies and the one across FDG-PET studies, which further supports this idea. Note 
however, that this descriptive disjunction should be considered with caution as only 
three FDG-PET studies had been included, and, accordingly, no method-specific 
subtraction analysis could be conducted. There were no FDG-PET studies available 
for lvPPA. Therefore, no conclusions can be drawn regarding potential differences for 
FDG-PET and MRI in lvPPA. Future meta-analyses on nfvPPA and lvPPA across 
FDG-PET studies (when more data are available) will show whether the disjunction 
between hypometabolism and atrophy found in svPPA can be replicated in other 
PPA variants. 
2.5 Limitations 
Results of the pilot meta-analysis on nfvPPA across FDG-PET studies and the 
descriptive disjunction between atrophy and hypometabolism in nfvPPA are 
considered to show trends based on the present state of knowledge, but should be 
interpreted cautiously as only three FDG-PET studies were included. Also for the 
meta-analysis on svPPA across FDG-PET studies and the meta-analysis on lvPPA, 
the number of clusters might be increased by future additionally involved studies. 
However, a previous ALE meta-analysis including MRI studies with svPPA and 
nfvPPA identified comparable clusters (Schroeter et al., 2008), supporting generally 
the stability and reliability of our findings. The clinical Neary criteria are not 
completely interchangeable with the clinical Gorno-Tempini criteria (see 
Supplementary Table A.3). Therefore, some of the patients diagnosed with nfvPPA 
according to the Neary criteria may actually have suffered from lvPPA. However, as 
in seven of the 11 MRI studies and in one of the three PET studies the authors 
explicitly differentiated between both variants of PPA, this bias had, if ever, a minor 
impact on our results. This assumption was confirmed by an analysis including only 
the seven MRI studies on nfvPPA that explicitly excluded subjects with lvPPA. As the 
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foci included in the ALE meta-analyses were reported by different research groups 
using different statistical approaches and thresholds, the results might be influenced 
by the methodological quality (e.g., sample size) of the single studies. This problem 
is partly addressed in the ALE meta-analysis method by modeling results of studies 
with smaller sample sizes by smaller Gaussian probability distributions than those of 
studies reporting larger sample sizes (Eickhoff et al., 2009). 
2.6 Conclusion 
We used anatomical likelihood estimation meta-analyses to validate and refine the 
new diagnostic imaging criteria for the different variants of PPA. As there was almost 
no overlap between the meta-analyses on semantic variant PPA, nonfluent variant 
PPA, and logopenic variant PPA across MRI studies, the new imaging criteria are 
highly distinctive. Limbic regions, in particular the posterior midcingulate gyrus and 
thalamus might play a larger role for logopenic variant PPA and semantic variant 
PPA as has been assumed until now. Finally, our results on semantic variant PPA 
suggest different diagnostic imaging criteria for FDG-PET than for MRI scans. Future 
meta-analyses on nonfluent variant PPA and logopenic variant PPA across FDG-
PET studies will show whether this disjunction between hypometabolism and atrophy 
also concerns the other variants of PPA.  
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3 Predicting Primary Progressive Aphasia with 
Support Vector Machine Approaches in 
structural MRI data 
3.1 Introduction 
Primary progressive aphasia (PPA) is a neurodegenerative disease with insidious 
onset mainly characterized by a language dysfunction that remains isolated for at 
least two years without significant impairment in other cognitive domains (Gorno-
Tempini et al., 2011; Mesulam, 1982; Neary et al., 1998). PPA subsumes three 
gradually progressive language disorders, namely semantic variant PPA (svPPA) or 
semantic dementia, nonfluent/agrammatic variant PPA (nfvPPA) or progressive 
nonfluent aphasia, and logopenic variant PPA (lvPPA) or logopenic progressive 
aphasia (Gorno-Tempini et al., 2008; Gorno-Tempini et al., 2004; Gorno-Tempini et 
al., 2011). SvPPA is mainly characterized by impairments in confrontation naming, 
single-word comprehension, and object-knowledge, as well as surface dyslexia or 
dysgraphia (Gorno-Tempini et al., 2011). The imaging supported diagnosis of svPPA 
is given when patients additionally show atrophy and/or hypometabolism in the 
anterior (ventral and lateral) temporal lobe. Patients suffering from nfvPPA show 
predominantly agrammatism, effortful halting speech with inconsistent speech sound 
errors and distortions (apraxia of speech), and impaired comprehension of 
syntactically complex sentences. These language deficits are often associated with 
atrophy or hypometabolism in left inferior frontal gyrus, insula, premotor, and 
supplementary motor areas. LvPPA is characterized by impaired single-word retrieval 
in spontaneous speech and naming as well as impaired repetition of sentences. 
Patients suffering from lvPPA furthermore often show phonologic paraphasias in 
spontaneous speech and naming. The imaging supported diagnosis of lvPPA is 
given when patients additionally show atrophy and/or hypometabolism in left 
posterior parietal, supramarginal, and angular gyri (Gorno-Tempini et al., 2011). The 
suggested imaging criteria have recently been validated by comprehensive meta-
analyses (Bisenius et al., 2016). 
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The prevalence of PPA is roughly estimated to range from 3-15/100,000 in the US 
population (Grossman, 2010; Harvey et al., 2003; Ratnavalli et al., 2002). PPA is thus 
a rare disease, which makes it very difficult for neurologists outside specialized 
clinics to correctly recognize and differentiate between the three PPA variants in 
routine hospital practice (e.g., Wilson et al., 2009). Given that the current imaging 
criteria are only supportive for the diagnosis of PPA, magnetic resonance imaging 
(MRI) scans are often not included as standard in the clinical assessment of PPA, but 
mainly used to exclude differential diagnoses (e.g., Wilson et al., 2009). It has been 
shown for other types of dementia like for instance, AD that changes in atrophy as 
visualized by MRI are an especially good biomarker for correct early diagnosis and 
furthermore even predictive for individuals with mild cognitive impairment to decline 
into AD (e.g., Frisoni et al., 2010; McEvoy and Brewer, 2010; Schroeter et al., 2009; 
Weiner et al., 2010). Therefore, it might be highly interesting to investigate whether 
MRI scans have a similar predictive value for the correct early diagnosis of PPA and 
to investigate which brain regions contribute the most to the classification of its three 
variants.  
On the one hand, it seems plausible that brain regions proposed in the current 
diagnostic imaging criteria and based on a large range of imaging studies (Bisenius 
et al., 2016; Gorno-Tempini et al., 2011) enable the correct diagnosis of the three 
PPA variants. On the other hand, most of the current imaging studies report 
comparisons of the three variants of PPA with age-matched healthy controls at a 
group-level and it has been critically discussed that statistical differences at group 
level might not necessarily reveal the most important regions to correctly diagnose 
individual cases (Davatzikos et al., 2008a; Davatzikos et al., 2008b; Wilson et al., 
2009). Therefore, it might advance our knowledge in this field crucially to investigate 
whether brain regions contributing the most to the correct diagnosis of the three PPA 
variants indeed correspond to regions that are especially atrophied in these three 
variants. Moreover, it might be highly interesting to explore whether disease-specific 
regions of interest (ROIs) in comparison with whole brain approaches even enhance 
the predictive power of MRI scans for the correct PPA classification. 
To address these issues, we investigated here atrophy, namely changes in grey 
matter density, with voxel-based morphometry (VBM) in patients suffering from one 
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of the PPA variants in comparison with healthy controls as well as by comparing 
patients with different PPA variants at a group level. Subsequently, we used linear 
support vector machine (SVM) classification of the individual grey matter density 
maps to investigate their discriminative or predictive power for the correct 
classification of single subjects as belonging to one of the PPA variants or healthy 
controls. A number of recent studies have used similar pattern classification methods 
to classify patients with AD, FTD, and mild cognitive impairment (Davatzikos et al., 
2008a; Davatzikos et al., 2008b; Dukart et al., 2013; Dukart et al., 2011; Fan et al., 
2008; Klöppel et al., 2008b; Lerch et al., 2008; Misra et al., 2009; Teipel et al., 2007; 
Vemuri et al., 2008). Wilson and colleagues (2009) investigated the utility of structural 
MRI scans for SVM classification in PPA variants in a single center study. Here, we 
investigated patients included in the multi-center study of the German consortium for 
frontotemporal lobar degeneration (FTLD; Otto et al., 2011) to replicate and 
generalize previously reported results, where the multi-center design is a 
precondition for application in clinical routine in the future. Additionally, we compared 
a whole-brain approach to a disease-specific ROI approach based on comprehensive 
anatomical likelihood estimation meta-analyses on the three variants of PPA 
(Bisenius et al., 2016). These ROIs represent the prototypical networks consistently 
affected in the three variants of PPA across MRI studies reporting group-level 
statistics. Note that these ROIs are based on a totally different cohort avoiding 
circularity. In order to better understand possible differences between the whole brain 
and the regions-of-interest approach, we furthermore computed and visualized the 
voxels that contributed the most to the SVM classification in the whole brain 
approach. To reveal whether the brain regions that contributed the most to the SVM 
classification in the whole brain approach corresponded to the regions that were 
especially atrophic in the three PPA variants, we also report pairwise group-level 
comparisons of grey matter probability maps between patients and healthy controls, 
respectively between PPA variants. For the pairwise group-level comparisons, we 
hypothesized that, according to the current imaging criteria and previously published 
VBM studies, atrophy is focused to left fronto-insular regions in nfvPPA, to the 
(mainly left) anterior temporal lobe in svPPA, and to the (predominantly left) posterior 
perisylvian or parietal cortex in lvPPA (e.g., Bisenius et al., 2016; Desgranges et al., 
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2007; Gorno-Tempini et al., 2011; Grossman et al., 2004; Mummery et al., 2000). 
Furthermore, we hypothesized that the same brain regions would mainly contribute to 
the correct SVM classification in PPA variants and healthy controls and that disease-
specific ROI approaches would reveal a higher predictive power for the SVM 
classification than whole-brain approaches. 
3.2 Materials and methods 
3.2.1 Subjects 
Patients and healthy controls were recruited within seven centers (located in Ulm, 
Munich, Leipzig, Homburg, Erlangen, Bonn, and Goettingen) of the German 
consortium for FTLD (http://www.ftld.de). All subjects gave written consent. The 
research protocol was in accordance with the latest version of the Declaration of 
Helsinki and approved by the universities’ ethics committees. For each center, the 
clinical evaluation and the assessment of the MRI scans were done on site according 
to standard operating procedures. That is, all of these centers used the same study 
protocol (diagnostic criteria, demographic, neuropsychological and language 
assessment, and scanning parameters), except for one center, where different 
scanning parameters were used (see section 2.2). The diagnosis of PPA required 
progressive deterioration of speech and that the main deficits were restricted to 
speech and language for at least two years. Patients were diagnosed more 
specifically with nfvPPA, svPPA, or lvPPA according to the newest diagnostic criteria 
(Gorno-Tempini et al., 2011). Note that data from the patient’s first visit in the multi-
centric FTLD consortium’s study was included guaranteeing the relevance of our 
results for early diagnosis of PPA syndromes. None of the patients included in this 
study had any comorbid psychiatric or neurodegenerative disease. The degree of 
clinical impairment of the patients was assessed using the Clinical Dementia Rating 
scale (CDR) and the FTLD-modified Clinical Dementia Rating scale (FTLD-CDR). We 
compared 44 right-handed patients suffering from a variant of PPA (16 nfvPPA, 17 
svPPA, and 11 lvPPA) with 20 right-handed healthy controls. We report all possible 
pairwise comparisons between PPA variants. Subjects from the larger group of a 
given group comparison were matched as closely as possible to the smaller group for 
1) number, 2) scanning parameter, 3) age, and where possible 4) gender. 
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3.2.2 Image acquisition 
All structural images were acquired on Siemens Magnetom 3T scanners (2xVerio, 
2xSkyra, 2xTrio, 1xAllegra, Erlangen, Germany). 47 T1-weighted images (12 svPPA, 
11 nfvPPA, ten lvPPA, 14 healthy controls) were acquired using a magnetization 
prepared rapid gradient echo sequence with a matrix=240x256x176, 
resolution=1x1x1 mm, field of view=240 mm, repetition time=2300 ms, echo 
time=2.98 ms, inversion time=900 ms, and flip angle=9°. For 17 subjects (five 
nfvPPA, five svPPA, one lvPPA, six healthy controls), T1-weighted images were 
acquired using a magnetization prepared rapid gradient echo sequence with a 
matrix=208x256x256, resolution=1x1x1 mm, field of view=256 mm, repetition 
time=2200 ms, echo time=4.38 ms, inversion time=1200 ms, and flip angle=8°. The 
distribution of the two sequences (scanning parameters) did not differ significantly, 
neither between patient groups nor between patient groups and healthy control 
groups (see Table 4). The very first MRI scans that were assessed as soon as the 
subjects were enrolled in the study, were used for analyses. 
3.2.3 Data analysis 
3.2.3.1 Clinical characteristics 
We used SPSS version 22 (IBM Corporation, Armonk, NY) to compute descriptive 
group scores (mean and standard deviation) for the overall patient and healthy 
control groups as well as for the respective subsets after matching for sample size, 
age, gender, and scanning parameters. Group comparisons for age, disease 
duration, education, and total grey matter density between all patient and healthy 
control groups as well as between PPA variants were performed using one-way 
ANOVAs, Kruskal-Wallis tests, and post-hoc t-tests in SPSS. Group comparisons for 
demographic and clinical characteristics between the matched subsets were 
performed using independent t tests (normally distributed data) and Mann-Whitney U 
tests (not normally distributed data) in SPSS. Group comparisons for gender and 
scanning parameter were done using chi-square tests in SPSS. 
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3.2.3.2 Voxel-based morphometry 
Images were processed with the VBM toolbox (http://dbm.neuro.uni-jena.de/vbm/) in 
SPM 8 (Wellcome Department of Imaging Neuroscience, London, UK; 
http://www.fil.ion.ucl.ac.uk/spm/software/spm8/) running in a MATLAB 8.5 
environment (Mathworks, Inc., Sherbon, MA, USA) using the default parameters. MRI 
images were segmented into grey matter, white matter, and cerebrospinal fluid using 
the unified segmentation module (Ashburner and Friston, 2005) and normalized to 
the standard Montreal Neurological Institute template including affine and non-linear 
modulation to account for local compression and expansion during transformation. 
The normalized segmented grey matter density maps were smoothed with a 
Gaussian kernel of 8 mm full-width-at-half-maximum. The group comparisons 
between the three variants of PPA and healthy controls as well as between PPA 
variants were performed in FSL (FMRIB Analysis Group, Oxford University, UK., 
http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSL) using permutation-based non-parametric 
testing (5000 permutations) with the Threshold-Free Cluster Enhancement (TFCE) 
method (Smith and Nichols, 2009; Winkler et al., 2014). Age, gender, and total grey 
matter were entered as covariates in the general linear model and results are 
reported at a family-wise error (FWE) corrected p < 0.05. 
SVM classification (Vapnik, 1995; Vapnik, 1998) was performed using libsvm version 
3.18 (Chang and Lin, 2001; https://www.csie.ntu.edu.tw/~cjlin/libsvm) in a MATLAB 
8.5 environment (Mathworks, Inc., Sherbon, MA, USA). Analyses were done using a 
linear kernel and the default solver C-SVC with C=1. In the training step, SVM 
assigns a weight to the scan of each subject which indicates its importance for the 
discrimination between groups. This weight is multiplied by a label vector which 
indicates the group of the scan (e.g., patient or healthy control). The cross-validation 
of the trained SVM was performed using the leave-one (subject)-out method. This 
procedure iteratively leaves-out the information of one subject of each group and 
trains the model on the remaining subjects for subsequent class assignment of the 
respective subject that was not included in the training procedure. This validation 
method allows the generalization of the trained SVM to data that have not been 
presented to the SVM algorithm previously and avoids the danger of inflating 
accuracies 
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In the whole brain approach, we included all voxels that had a probability for grey 
matter higher than 0.2 (because voxels lying between white matter and ventricular 
cerebrospinal fluid tend to be misclassified as grey matter (e.g., Ashburner and 
Friston, 2000; Dukart et al., 2011). In the ROI approach, we used the results from a 
recently published anatomical likelihood estimation meta-analysis on the three 
variants of PPA (p < 0.05 false discovery rate corrected) across MRI studies as a 
prototypical disease-specific template (Bisenius et al., 2016). The original meta-
analytic clusters were coregistered to the Montreal Neurological Institute template of 
the VBM results using SPM 8 and dilated by two voxels using the 3 D dilation 
function implemented in the WFU PickAtlas (Maldjian, 
http://www.nitrc.org/projects/wfu_pickatlas). Non-parametric statistical comparisons 
were calculated between the performance (as indicated by the area under the 
receiver operating characteristic curve, AUC) of the ROI approach and the whole 
brain approach for all pairwise comparisons at p<0.05 in StAR (Vergara et al., 2008; 
www.melolab.org/star/home.php). In order to determine and visualize the importance 
of each voxel for the discrimination between groups in the whole brain approach, we 
multiplied each grey matter probability map (containing only voxels where p > 0.2) by 
the product of weight and label and summed on a voxel basis (Klöppel et al., 2008b). 
3.3 Results 
3.3.1 Demographic and clinical characteristics 
The demographic and clinical characteristics of the overall patient and healthy control 
groups are shown in Table 1. The patient and healthy control groups did not differ 
significantly from each other in age, education, or disease duration. The patient and 
healthy control groups differed however significantly in total grey matter density 
(F(3,63)=4.06, p=0.01) with svPPA and lvPPA showing lower values than healthy 
controls. The three PPA variants did not differ significantly from each other in age, 
education, disease duration, or total grey matter density.  
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Table 4 Demographic and clinical characteristics of patients and healthy controls 
 nfvPPA svPPA lvPPA HC  
number 16 17 11 20 
gender (m/f) 8/8 11/6 4/7 11/9 
scanning parameter 11/5 12/5 10/1 14/6 
age (years) 67.50 ± 7.42 62.53 ± 7.77 65.36 ± 6.25 67.05 ± 6.61 
education (years) 13.19 ± 4.29 15.35 ± 3.37 13.27 ± 3.35 14.10 ± 3.04 
disease duration (years) 2.19 ± 1.60 3.59 ± 2.45 3.64 ± 2.66 - 
total grey matter densitiy 
(dm3) 
0.54 ± 0.08 0.52 ± 0.08 0.51 ± 0.09 0.59 ± 0.05 
CDR 3.44 ± 3.20 5.32 ± 4.19 4.64 ± 4.43 0.03 ± 0.11 
FTLD-CDR 5.94 ± 4.07 7.88 ± 5.44 6.86 ± 5.81 0.05 ± 0.15 
CERAD Plus (test battery)     
MMSE 19.94 ± 7.25 19.31 ± 8.35 22.10 ± 6.03 28.70 ± 0.92 
word list memory (trials 1-3)  13.07 ± 6.61 13.92 ± 7.62 11.64 ± 8.93 23.40 ± 3.03 
word list recall 4.33 ± 2.62 3.77 ± 3.30 3.73 ± 3.88 8.20 ± 2.38 
word list recognition (yes) 8.57 ± 2.41 8.85 ± 1.41 9.10 ± 1.20 9.80 ± 0.52 
word list recognition (no) 9.57 ± 0.65 7.69 ± 2.63 8.40 ± 3.34 10.00 ± 0.00 
constructional praxis 9.06 ± 1.95 10.00 ± 2.08 8.18 ± 3.31 11.00 ± 0.00 
constructional praxis recall 6.75 ± 2.86 6.31 ± 4.31 4.55 ± 4.28 9.45 ± 1.91 
Trail Making Test A (s) 94.38 ± 46.95 75.69 ± 51.56 75.80 ± 51.33 35.80 ± 9.01 
Trail Making Test B (s) 220.18 ± 91.33 123.70 ± 72.24 201.13 ± 84.47 74.50 ± 19.12 
Boston Naming Test 9.93 ± 4.76 6.47 ± 4.26 10.18 ± 3.89 14.85 ± 0.49 
Verbal Fluency Test  8.06 ± 7.34 8.00 ± 5.01 12.09 ± 8.49 26.75 ± 5.50 
Phonemic Fluency Test  3.87 ± 4.09 7.23 ± 5.29 6.80 ± 4.52 18.20 ± 4.63 
Repeat and Point Test     
Repeat task 7.93 ± 2.34 8.93 ± 1.98 6.80 ± 3.36 10.00 ± 0.00 
Point task 8.53 ± 1.55 6.14 ± 2.85 8.10 ± 1.91 9.88 ± 0.49 
CDR clinical dementia rating scale, global score, CERAD Consortium to Establish a Registry for 
Alzheimer’s Disease, FTLD frontotemporal lobar degeneration, HC healthy controls, lvPPA logopenic 
variant PPA, MMSE Mini-Mental State Examination, nfvPPA nonfluent/agrammatic variant PPA, PPA 
primary progressive aphasia, svPPA semantic variant PPA. Note age, education, disease duration, 
CDR, FTLD-CDR, CERAD Plus, and Repeat and Point Test are indicated as mean ± standard 
deviation. Note that data was missing for a few subjects on some subtests of the CERAD Plus and the 
Repeat and Point Test. 
A detailed description of each of the pairwise comparisons between the matched 
subsets is given in Supplementary Table B.1. As shown in Table B.1, no pair of 
groups differed significantly in age, gender, and education and none of the patient 
groups differed significantly from the other patient groups in age, gender, education, 
duration of disease, CDR, and FTLD-CDR. PPA variants differed significantly from 
healthy controls in CDR, FTLD-CDR, and most of the subtests of the Consortium to 
Establish a Registry for Alzheimer’s Disease (CERAD) Plus test battery. NfvPPA and 
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svPPA additionally differed significantly from healthy controls in the Repeat and Point 
Test. In the pairwise comparisons between PPA variants, svPPA showed a 
significantly lower test score in the Point task than nfvPPA and a significantly higher 
test score in the Repeat task than lvPPA (see Supplementary Table B.1). 
3.3.2 Voxel-based morphometry results 
Significant results of the statistical comparison between grey matter density maps of 
healthy controls and patients are shown in red (nfvPPA), light green (svPPA), and 
blue (lvPPA) color in Figures 6-8 on the top left (for more details, see Supplementary 
Table B.2). All results are reported at an FEW corrected significance level of p < 
0.05. The results of the statistical comparison between grey matter density maps of 
svPPA and nfvPPA are shown in Figure 9 on the top left (svPPA < nfvPPA in light 
green color, nfvPPA < svPPA in red color). The results for the statistical comparison 
between lvPPA and svPPA are shown in Figure 10 on the top left (svPPA < lvPPA in 
light green color, lvPPA < svPPA no significant results at p < 0.05). There were no 
significant results for the comparison between lvPPA and nfvPPA at a FEW corrected 
significance level of p < 0.05 (therefore not shown). More details on the pairwise 
comparisons between PPA variants are given in Supplementary Table B.2. 
3.3.3 Support vector machine classification results 
SVM classification was applied separately to each group comparison: 1) nfvPPA vs. 
healthy controls, 2) svPPA vs. healthy controls, 3) lvPPA vs. healthy controls, and 4) 
svPPA vs. nfvPPA. The reported accuracy is the percentage of subjects correctly 
assigned to the clinical diagnosis (patient/healthy control or svPPA/nfvPPA). 
Sensitivity refers to the proportion of patients correctly classified as patients and 
specificity to the proportion of healthy controls correctly classified as healthy controls. 
Positive predictive value refers to the number of correctly classified patients out of all 
subjects classified as patients and negative predictive value refers to the number of 
correctly classified healthy controls out of all subjects classified as healthy controls. 
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3.3.3.1 Group comparisons between patients and healthy controls 
Figure 6: Voxel-based morphometry and support vector machine classification results for 
nonfluent/agrammatic variant PPA as compared to healthy controls. Top left: voxel-based 
morphometry (VBM) results for the comparison between nonfluent/agrammatic variant PPA (nfvPPA) 
and healthy controls (HC) (family-wise error corrected p < 0.05). Bottom left: Regions of interest 
(ROIs) based on independent meta-analyses. Right: Results of support vector machine classification 
(SVM) classification. Top: Regions most relevant for classification as patients in yellow, HC in light 
green. Note that the scale of the distance weights has no applicable units. Bottom: Sensitivity, 
specificity, and accuracy for the ROI approach and the whole brain approach in SVM classification. 
The accuracy for the classification between different variants and healthy controls 
using the leave-one-out approach ranged from 91 to 97 % for the whole brain 
approach and from 82 to 100 % for the ROI approach. Details on the respective 
sensitivity, specificity, and accuracy are given in Figures 6-8 on the bottom right and 
details on positive and negative predictive values are shown in Supplementary Table 
B.3. The results of the SVM classification between patients and healthy controls for 
the whole brain approach are shown on the top right of Figures 6-8. Here, values 
range between -1 and 0 or 0 and 1 and reflect the relative importance of these voxels 
in the discrimination between both groups. Voxels that contributed the most to the 
classification of subjects as patients (i.e., had a higher negative value) are depicted in 
yellow and the voxels that contributed the most to the classification of subjects as 
healthy controls (i.e., had a higher positive value) are shown in light green. A value 
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near 0 indicates that this voxel was neither indicative for the classification as patient 
nor as healthy control. 
Brain regions that contributed the most to the classification of subjects as nfvPPA vs. 
control subjects (Figure 6 on the top right) encompass bilaterally cerebellum, inferior, 
middle, and superior temporal gyri, middle occipital gyrus, parahippocampal gyrus, 
crus cerebri, thalamus, precuneus, inferior and superior frontal gyri, as well as in the 
left hemisphere orbital gyrus, insula, pre- and postcentral gyri, middle frontal gyrus, 
and angular gyrus. Classification accuracy was 91 % for the whole brain approach 
and 84 % for the ROI approach. The statistical comparison between both approaches 
revealed high AUC values, but without significant differences (AUCROI=0.90, AUCwhole 
brain=0.94, p=0.48). 
Figure 7: Voxel-based morphometry and support vector machine classification results for semantic 
variant PPA as compared to healthy controls. Top left: voxel-based morphometry (VBM) results for the 
comparison between semantic variant PPA (svPPA) and healthy controls (HC) (family-wise error 
corrected p < 0.05). Bottom left: Regions of interest (ROIs) based on independent meta-analyses. 
Right: Results of support vector machine (SVM) classification. Top: Regions most relevant for 
classification as patients in yellow, HC in light green. Note that the scale of the distance weights has 
no applicable units. Bottom: Sensitivity, specificity, and accuracy for the ROI approach and the whole 
brain approach in SVM classification. 
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Regions that contributed the most to the classification of subjects as svPPA vs. 
control subjects included bilaterally (although predominantly in the left hemisphere) 
cerebellum, inferior, middle and superior temporal gyri, middle occipital gyrus, 
parahippocampal gyrus, hippocampus, amygdala, putamen, insula, precentral and 
postcentral gyri, middle frontal gyrus, inferior parietal gyrus, and cingulate gyrus (see 
Figure 7 on the top right). Classification accuracy was very high for both approaches 
(97 % for the whole brain approach and 100 % for the ROI approach). The statistical 
comparison between approaches showed very high AUC values for both, but without 
significant differences (AUCROI=1.00, AUCwhole brain=0.97, p=0.32). 
Figure 8: Voxel-based morphometry and support vector machine classification results for logopenic 
variant PPA as compared to healthy controls. Top left: voxel-based morphometry (VBM) results for the 
comparison between logopenic variant PPA (lvPPA) and healthy controls (HC) (family-wise error 
corrected p < 0.05). Bottom left: Regions of interest (ROIs) based on independent meta-analyses. 
Right: Results of support vector machine (SVM) classification. Top: Regions most relevant for 
classification as patients in yellow, HC in light green. Note that the scale of the distance weights has 
no applicable units. Bottom: Sensitivity, specificity, and accuracy for the ROI approach and the whole 
brain approach in SVM classification. 
Regions that contributed the most to the classification of subjects as lvPPA patients 
vs. control subjects are shown in yellow in Figure 8 on the top right and encompass 
left inferior temporal gyrus, fusiform gyrus, middle occipital gyrus, parahippocampal 
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gyrus, hippocampus, putamen, insula, thalamus, precentral gyrus, middle and 
superior frontal gyri, angular gyrus, supramarginal gyrus, and cingulate gyrus as well 
as bilaterally cerebellum, middle and superior temporal gyri, caudate nucleus, 
thalamus, middle and superior frontal gyri, precuneus, and superior parietal gyrus. 
Classification accuracy was high for both, the whole brain approach (95 %) and the 
ROI approach (82 %). The statistical comparison between both approaches did show 
high AUC values without significant differences (AUCROI=0.91, AUCwhole brain=0.95, 
p=0.38). 
3.3.3.2 Group comparisons between PPA variants 
Figure 9 illustrates on top right in yellow the regions that contributed the most to the 
classification as svPPA and in green the regions that contributed the most to the 
classification as nfvPPA. Here, sensitivity refers to the ratio of correctly classified 
svPPA patients and specificity to the ratio of correctly classified nfvPPA patients. 
Details on positive and negative predictive values are given in Supplementary Table 
B.3. The regions that contributed the most to the classification of a subject as svPPA 
included bilaterally cerebellum, inferior, middle and superior temporal gyri, middle 
occipital gyrus, fusiform gyrus, parahippocampal gyrus, hippocampus, putamen, 
insula, cuneus, precuneus, inferior frontal gyrus, superior parietal gyrus, cingulate 
gyrus, and left precentral gyrus. Regions that contributed the most to the 
classification of nfvPPA included bilateral cerebellum, middle and superior occipital 
gyrus, superior temporal gyrus, gyrus rectus, posterior orbital gyrus, caudate nuclei, 
thalamus, inferior, middle, and superior frontal gyrus, precentral gyrus, postcentral 
gyrus, inferior parietal gyrus, angular gyrus, supramarginal gyrus, right precuneus, 
right superior parietal gyrus, and right cingulate gyrus. Classification accuracy was 
78 % for both, the whole brain and the ROI approach. Both approaches revealed 
high AUC values without significant differences between them (AUCROI=0.87, 
AUCwhole brain=0.88, p= 0.72). 
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Figure 9: Support vector machine classification results for the comparison and discrimination between 
semantic variant PPA and nonfluent/agrammatic variant PPA. Top left: VBM results for the comparison 
between semantic variant PPA (svPPA) and nonfluent/agrammatic variant PPA (nfvPPA) 
(svPPA<nfvPPA green, nfvPPA<svPPA red, family-wise error corrected p < 0.05). Bottom left: 
Regions of interest (ROIs) based on independent meta-analyses. Right: Results of support vector 
machine (SVM) classification. Top: Regions most relevant for classification as svPPA in yellow, 
nfvPPA in light green. Note that the scale of the distance weights has no applicable units. Bottom: 
Sensitivity, specificity, and accuracy for the ROI approach and the whole brain approach in SVM 
classification. 
Figure 10 illustrates on top right in yellow the regions that contributed the most to the 
classification as lvPPA and in green the regions that contributed the most to the 
classification as svPPA. Sensitivity refers to the ratio of correctly classified lvPPA 
patients and specificity to the ratio of correctly classified svPPA patients. Positive and 
negative predictive values are given in Supplementary Table B.3. The regions that 
contributed the most to the classification of a subject as lvPPA included bilateral 
cerebellum, middle occipital gyrus, middle and superior temporal gyri, caudate nuclei, 
thalamus, superior frontal gyrus, supramarginal gyrus, angular gyrus, precuneus, 
cingulate gyrus, right lateral orbital gyrus, inferior and middle frontal gyrus, and 
superior parietal gyrus. Regions that contributed the most to the classification of 
svPPA included bilateral cerebellum, inferior, middle, and superior temporal gyrus, 
parahippocampal gyrus, hippocampus, insula, and right putamen. Classification 
accuracy was 95 % for both, the whole brain and the ROI approach. Both 
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approaches reached high AUC values without significant differences between them 
(AUCROI=0.91, AUCwhole brain=0.93, p=0.41). 
Figure 10: Support vector machine classification results for the comparison and discrimination 
between logopenic variant PPA and semantic variant PPA. Top left: VBM results for the comparison 
between logopenic variant PPA (lvPPA) and semantic variant PPA (svPPA) (svPPA<lvPPA family-
wise error corrected p < 0.05). Bottom left: Regions of interest (ROIs) based on independent meta-
analyses. Right: Results of support vector machine (SVM) classification. Top: Regions most relevant 
for classification as lvPPA in yellow, svPPA in light green. Note that the scale of the distance weights 
has no applicable units. Bottom: Sensitivity, specificity, and accuracy for the ROI approach and the 
whole brain approach in SVM classification. 
Figure 11 illustrates on top in yellow the regions that contributed the most to the 
classification as lvPPA and in green the regions that contributed the most to the 
classification as nfvPPA. Sensitivity refers to the ratio of correctly classified lvPPA 
patients and specificity to the ratio of correctly classified nfvPPA patients. For details 
on positive and negative predictive values see Supplementary Table B.3. The 
regions that contributed the most to the classification of a subject as lvPPA included 
bilateral cerebellum, inferior, middle occipital gyrus, middle and superior temporal 
gyri, thalamus, putamen, middle and superior frontal gyrus, supramarginal gyrus, 
angular gyrus, precentral gyrus, cingulate gyrus, precuneus, superior parietal gyrus. 
Regions that contributed the most to the classification of nfvPPA included right 
inferior temporal gyrus, bilateral middle and superior temporal gyri, gyrus rectus, 
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lateral orbital gyrus, insula, caudate nuclei, cuneus, cingulate gyrus, middle and 
superior frontal gyri, postcentral gyrus, supramarginal gyrus, and superior parietal 
gyrus. Classification accuracy was low with 55 % for the whole brain approach and 
higher with 64 % for the ROI approach. AUC values were comparable, namely higher 
for the ROI than the whole brain approach, but without significant differences 
between them (AUCROI=0.64, AUCwhole brain=0.59, p=0.50). 
Figure 11: Support vector machine 
classification results for the discrimination 
between logopenic variant PPA and 
nonfluent/agrammatic variant PPA. Top: 
Regions most relevant for support vector 
machine classification as logopenic variant 
PPA (lvPPA) in yellow, nonfluent/agrammatic 
variant PPA (nfvPPA) in light green. Note that 
the scale of the distance weights has no 
applicable units. VBM results are not shown 
for the group comparisons, because no 
significant results were obtained. Middle: 
Sensitivity, specificity, and accuracy for the 
ROI approach and the whole brain approach 
in SVM classification. Bottom Regions of 
interest (ROIs) based on independent meta-
analyses. 
 
 
 
3.4 Discussion 
To our knowledge, this is the first study demonstrating that SVM classification in 
multi-center MRI data can be used to diagnose and dissociate PPA subtypes, where 
the multi-center design is a precondition for application in clinical routine in the future. 
Moreover, we compare a whole brain vs. data-driven disease-specific ROI approach 
for SVM classification. We used ROIs reported in a recent comprehensive meta-
analysis on PPA (Bisenius et al., 2016). In order to reveal whether the regions that 
contributed the most to the whole brain SVM classification of the three variants of 
PPA corresponded to the regions that were especially atrophic in the respective 
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variant, we additionally conducted statistical group-level comparisons between 
patient groups and healthy control groups. In the following, we are going to introduce 
the results of these group-level comparisons, before we discuss in more detail the 
results of the SVM classification for the whole brain approach and the ROI approach 
as well as possible further implications. 
3.4.1 Atrophy in the different variants of primary progressive aphasia 
The group comparisons in our study revealed regional brain atrophy that included the 
disease-specific brain areas identified in comprehensive systematic and quantitative 
meta-analyses across imaging studies from the literature, if one compares this data 
for each PPA variant (see left top and bottom images in Figures 6-8). Beyond that our 
group-level comparisons are in line with studies showing that, with the progression of 
the disease, the atrophic networks in the three subtypes of PPA partly converge (e.g., 
Gorno-Tempini et al., 2011; Rogalski et al., 2011). Mild and early svPPA has been 
shown to involve atrophy in (predominantly left) anterior temporal lobe, with extension 
to the adjacent temporoparietal junction, hippocampus and amygdala and posterior 
orbital cortex as well as in the right anterior temporal lobe (Czarnecki et al., 2008; 
Grossman, 2010 Krueger et al., 2010; Mesulam et al., 2012; Rohrer et al., 2008) and 
to progress bilaterally into posterior and superior temporal lobe, left temporoparietal 
junction, bilateral cingulate cortex and orbitofrontal gyri, left superior orbitofrontal 
gyrus, left inferior and superior frontal gyri (e.g., Grossman, 2010; Kumfor et al., 
2016; Rogalski et al., 2011). Early and mild stages of nfvPPA, on the other hand, 
have been shown to be characterized by atrophy in left inferior frontal gyrus, 
temporoparietal junction, anterior superior temporal gyrus, posterior middle frontal 
gyrus and precentral gyrus (Mesulam et al., 2012) and to progress into left anterior 
temporal lobe, orbital cortex, dorsolateral prefrontal cortex, anterior cingulate cortex, 
and along the perisylvian fissure into the parietal lobe (e.g., Grossman 2010; 
Rogalski et al., 2011). For lvPPA, atrophy has been shown to progress from 
(predominantly left) posterior superior temporal cortex, inferior parietal cortex, 
posterior cingulate cortex and medial temporal cortex into the anterior and lateral 
temporal cortex, caudate nucleus, insula, inferior frontal gyrus and dorsal frontal 
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cortex as well as into the temporo-parietal junction, posterior cingulate and 
precuneus of the right hemisphere. (e.g., Rogalski et al., 2011; Rohrer et al., 2013).  
3.4.2 Support vector machine classification is a useful tool to differentiate 
between healthy controls and primary progressive aphasia variants 
Accuracies for the whole brain approach in SVM classification between patients and 
healthy controls ranged from 91 % for nfvPPA over 95 % for lvPPA to 97 % for 
svPPA. The between-subtype whole brain SVM classification enabled high accuracy 
of 78 and 95 % for the discrimination between svPPA vs. nfvPPA and svPPA vs. 
lvPPA variant. Only for the discrimination between nfvPPA and lvPPA variants 
accuracy was low with 55 %. These numbers are in line with previously reported 
accuracies ranging from 58-100 % in studies on neurodegenerative diseases like AD 
(e.g., (e.g., Chetelat and Baron, 2003; Davatzikos et al., 2008b; Dukart et al., 2013; 
Dukart et al., 2011; Klöppel et al., 2008b; Lerch et al., 2008; Teipel et al., 2007; 
Vemuri et al., 2008), mild cognitive impairment (e.g., Davatzikos et al., 2008a; Teipel 
et al., 2007), FTD (e.g., Davatzikos et al., 2008b; Dukart et al., 2011; Klöppel et al., 
2008a), and PPA (Wilson et al., 2009; Zhang et al., 2013).  
Until now, there has only been one study investigating the three variants of PPA with 
SVM classification (Wilson et al., 2009). These authors performed a principal 
component analysis on MRI scans from one study center and subsequently used the 
results for the pairwise SVM classification between patients and healthy controls as 
well as between the three patient groups. Wilson et al. (2009) found an accuracy of 
100 % for the discrimination between svPPA patients and healthy controls, 100 % for 
the classification between lvPPA patients and healthy controls, and an accuracy of 
89 % for the discrimination between nfvPPA and healthy controls. These authors 
report an accuracy of 89 % for the discrimination between svPPA and nfvPPA 
patients, 93.8 % for svPPA vs. lvPPA, and 81.3 % for lvPPA vs. nfvPPA. Our SVM 
results using the whole brain approach on grey matter density maps in the multi-
center cohort of the FTLD consortium are thus comparable with the results of Wilson 
et al. (2009) with regard to the classification between patients and healthy controls 
showing higher accuracies for svPPA and lvPPA than for nfvPPA and the 
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classification between lvPPA and nfvPPA showing a lower classification accuracy 
than the other classifications between PPA variants.  
Additionally, we performed group-level comparisons on the grey matter density maps 
between patients and healthy controls as well as between PPA variants in order to 
investigate whether the regions that contributed the most to the SVM classification of 
patients also corresponded to the regions mostly atrophied in these patients. Figures 
7 and 8 show that brain regions that were most consistently atrophied in svPPA and 
lvPPA indeed also contributed the most to the SVM classification of these patients. 
For nfvPPA, on the other hand, brain regions that contributed the most to the SVM 
classification as patients were not constrained to the regions that were atrophied in 
our nfvPPA patients, but also encompassed very similar regions in the contralateral 
(right) hemisphere (see Figure 6). A possible explanation for the importance of the 
additional brain regions in the right hemisphere might be that they were affected to a 
lesser extent (and thus not significant in the group-level comparison) and that SVM 
classification as a more sensitive method already took into account early atrophy in 
these regions. There is a general consensus that the results of group-level statistics 
might not be applicable to individual scans, because their sensitivity and specificity at 
early stages of brain pathology is insufficient for the prediction of the status of 
individual scans (Davatzikos et al., 2008b; Fan et al., 2008; Wilson et al., 2009).  
Interestingly, for the discrimination between svPPA and nfvPPA, the regions that 
contributed to the SVM classification as svPPA patients (see Figure 9 on the top), 
corresponded to the regions that were most consistently atrophied in these patients 
(see Figure 7 on the top left). The regions that contributed to the SVM classification 
as nfvPPA, on the other hand, were (except for two characteristic regions in the 
inferior and middle frontal gyri) rather spread. This might be due to the fact that the 
group comparisons between patients and healthy controls showed for both, svPPA 
and nfvPPA, significant atrophy in the superior temporal gyrus, parahippocampal 
area, hippocampus, insula, and inferior frontal gyrus (see Figures 6 and 7 on the top 
left). Although atrophy in the superior temporal gyrus, parahippocampal area, and 
hippocampus have been discussed to be rather specific for svPPA, while insula, and 
inferior frontal gyrus have been discussed to be rather characteristic for nfvPPA, it 
has been shown in longitudinal studies that with the progression of the disease, the 
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atrophic networks in the three variants of PPA partly converge (e.g., Gorno-Tempini 
et al., 2011; Rogalski et al., 2011). Given that on the one hand several regions might 
be affected similarly in nfvPPA and svPPA depending upon the current stage of the 
respective disease and on the other hand structural MRI scans do not provide any 
information regarding the temporal dynamic pattern of brain atrophy, the SVM 
classification method, given its high sensitivity, might not always be able to perfectly 
discriminate between these two variants. For both subtype-specific classifications, 
svPPA vs. nfvPPA and svPPA vs. lvPPA, we reached a high classification accuracy, 
although the number of patients was rather low for lvPPA and the respective 
comparison. The high accuracy might be related to a relatively strong (in the sense of 
high t-values) and regionally focused atrophy in svPPA. This is obvious in the group 
comparisons revealing much higher atrophy in svPPA than nfvPPA or lvPPA, 
whereas nfvPPA showed stronger atrophy only in a very small area and lvPPA did 
not show any atrophy in comparison with svPPA. Note that disease duration and 
severity did generally not significantly differ between PPA subtypes excluding these 
factors as explanation for differences in classification accuracy. 
As stated before the whole-brain SVM classification between nfvPPA and lvPPA 
variants reached only a low accuracy. This might be related to relatively small and 
rather distributed atrophy in these two PPA variants or to conceptual issues. In a 
prospective data-driven study, Sajjadi et al. (2012) examined to which extent PPA 
patients would be classifiable according to the revised clinical diagnostic criteria and 
which linguistic impairments would cluster together (and thus form distinct 
syndromes) using principal factor analysis. In this cohort, 58.7 % of the patients could 
be assigned to one of the three variants of PPA proposed by Gorno-Tempini et al. 
(2011), while 41.3 % of the patients were classified as mixed PPA because their 
deficits either extended beyond a single PPA variant or they met the diagnostic 
criteria for more than one variant. The principal factor analysis identified two clear 
syndromes corresponding to the proposed syndromes of svPPA and nfvPPA as well 
as a residual miscellany. Interestingly, impaired sentence repetition, which has been 
proposed as a cardinal diagnostic feature for lvPPA, aligned with the factor 
corresponding to nfvPPA. One might therefore speculate that low classification 
accuracy between nfvPPA and lvPPA in imaging data might not only be related to the 
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rather relatively small and distributed atrophy, but possibly also to problems in 
clinically distinguishing both PPA syndromes.  
3.4.3 Regions-of-interest approach or whole brain approach? 
We compared the whole brain approach for SVM classification with an ROI approach 
using ROIs from a recent meta-analysis on the three variants of PPA (Bisenius et al., 
2016). A similar approach has already been adopted by Dukart and colleagues who 
compared the whole brain versus ROI approach for SVM classification between FTD 
and AD as well as between these patient groups and healthy controls using structural 
MRI and PET scans (Dukart et al., 2013; Dukart et al., 2011). These authors reported 
that for MRI scans, the ROI approach was comparable to the whole brain approach 
for the discrimination between patients and healthy controls, but had a lower 
accuracy for the discrimination between patient groups (AD vs. FTD) (Dukart et al., 
2013; Dukart et al., 2011). In the current study, the ROI approach reached generally 
a high accuracy in diagnosis and, at least mainly, differential diagnosis/classification 
of PPA syndromes, comparable to the whole-brain approach. In detail, it showed a 
higher accuracy as compared to healthy controls for svPPA patients and a slightly 
lower accuracy for nfvPPA and lvPPA patients, while it showed a similar accuracy for 
svPPA vs. nfvPPA and svPPA vs. lvPPA patients as compared to the whole brain 
approach. Remarkably, for the lvPPA vs. nfvPPA comparison the ROI approach 
showed a higher accuracy than the whole brain approach, may be due to the 
diffusivity and similar strength (in the sense of t-values) of brain atrophy requiring 
higher regional specificity for the analysis. One might speculate that ROI-based 
classification might be given preference for special questions in differentiating 
between syndromes in the future. Given however that none of these trends was 
statistically significant, we consider both approaches as equally valid.  
The visual comparison between the whole brain approach and the ROI approach 
raises however the question about the optimal method to choose ROIs for SVM 
classification in PPA. The optimal number of ROIs for SVM classification needs to be 
such as to accurately capture all subtleties of the structural abnormality in these 
patients and thus achieve a sufficient predictive accuracy without however reducing 
predictive accuracy through the increase of noise that possibly accompanies 
 3. Support vector machine classification in primary progressive aphasia 
55 
 
additional ROIs that are less relevant to the classification. Selecting ROIs based on 
group-level comparison between patients and healthy control groups might for 
instance provide a higher discriminative power for the SVM classification in the same 
study sample. These ROIs would however be biased to at least some extent by the 
specific study sample and might therefore not necessarily lead to similar good results 
in other study samples. Another possibility to find the optimal ROIs for the SVM 
classification between nfvPPA (or lvPPA) and healthy controls might consist in 
rerunning meta-analyses on the three variants of PPA across MRI studies using a 
less conservative statistical threshold. This methodological approach might no longer 
exclusively reveal the brain regions that are specific to a given variant (and to some 
extent possibly even false positive results), but due to the higher sensitivity, also 
common networks between variants that become usually only visible in longitudinal 
studies monitoring the progression of the disease (e.g., Rogalski et al., 2011). For the 
ROI approach of SVM classification between the different variants of PPA, on the 
other hand, it might be rather promising to only consider ROIs that are either more 
severely impaired in one variant as in the other variants as for instance the inferior 
and middle temporal gyri in svPPA, or rather specific to the given variant (e.g., middle 
frontal gyrus in nfvPPA as compared to svPPA). The considerations regarding the 
optimal ROI for SVM classification in PPA are however purely hypothetical and need 
to be investigated in future studies. 
Furthermore, it might be interesting to compare the ROI approach to the whole brain 
approach using combined imaging data as for instance MRI and PET as has already 
been done for AD and FTD (e.g., Davatzikos et al., 2008b; Dukart et al., 2013; Dukart 
et al., 2011) or using MRI and diffusion tensor imaging data as has been done by 
Zhang et al. (2013), who showed, in a small sample, higher accuracies for whole 
brain SVM classification of diffusion tensor imaging data than of MRI data for nfvPPA 
and svPPA versus healthy controls. Moreover, the potential of ROI approaches for 
disease classification has to be validated in longitudinal studies, where one would 
assume higher accuracy in early stages.  
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3.5 Limitations 
The relatively small number of subjects might hamper the generalization of the 
results to the overall population of PPA patients. Given however that our results are 
very similar to another study including more patients but using a different approach 
(Wilson et al., 2009) this should not really constitute a major issue. A problem that 
might occur in pattern classification methods is the risk of overfitting the data due to 
the high-dimensionality of the data, which can however be reduced by using the 
leave-one out approach as has been done in the current study. Segmentation and 
normalization processes are not always perfect which might result in underestimation 
of atrophy in patients or underestimation of grey matter in healthy controls, which 
leads to lower accuracies in the SVM classification. This issue should however at 
least partly be addressed in the current study as that our data have been acquired on 
different scanners and were well balanced between patient and healthy control 
groups. Finally, the classification between pairs of groups was a highly idealized 
situation that does not reflect the problem in the real world of differential diagnosis 
between several neurological diseases with different prevalence rates – an issue that 
has to be addressed in future studies validating the application of SVM approaches in 
every day diagnostic life. 
3.6 Conclusion 
Our study aimed at validating the potential of structural multi-center MRI data for 
disease classification in PPA. We compared the whole brain approach with a 
disease-specific ROI approach for SVM classification in the three variants of PPA. 
Generally, both the whole brain and the disease-specific approach reached high 
classification accuracy in diagnosis and differential diagnosis of PPA syndromes 
without significant differences. Our results showed that for svPPA, the ROI approach 
using prototypical disease-related networks as revealed by meta-analyses across 
MRI studies revealed a higher accuracy (perfect discrimination of 100 %) than the 
whole brain approach. For nfvPPA and lvPPA on the other hand, the SVM 
classification showed higher accuracies when using the whole brain approach. The 
regions contributing to the correct SVM classification of patients mostly corresponded 
to regions that were consistently atrophied in these patients as shown by the VBM 
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results. For the discrimination between svPPA and nfvPPA, and between svPPA and 
lvPPA the whole brain approach and the ROI approach showed similar results. The 
ROI approach increased accuracy in classification between lvPPA and nfvPPA in 
comparison with the whole brain approach, which might be related to the diffusivity 
and similar strength (in the sense of t-values) in these PPA syndromes requiring 
higher regional specificity for the analysis. Given that the accuracies for SVM 
classification using the ROI approach were still quite high despite the relatively small 
size of the chosen ROIs as compared to the regions that were taken into account in 
the whole brain SVM classification of the respective patients, future studies shall 
further explore the potential of the ROI approach using different ROIs for SVM 
classification of PPAs. 
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4 General Discussion 
In the revised diagnostic criteria for PPA (Gorno-Tempini et al., 2011), more 
importance is attributed to the assessment of imaging scans as has been the case in 
the previous consensus diagnostic criteria for PPA (Neary et al., 1998). The current 
imaging criteria have been proposed based on a qualitative evaluation of the 
literature in this field. Here, we provided a quantitative evaluation of the currently 
available MRI and PET studies in order to statistically validate the proposed 
diagnostic imaging criteria using ALE meta-analyses. Thereafter, we investigated the 
diagnostic value of MRI scans for early individual diagnosis of PPA in clinical routine 
using support vector machine classification and explored whether focusing 
exclusively on prototypical networks for the single PPA variants would ameliorate the 
diagnostic value of MRI scans. In the following, we are not going to discuss in detail 
the results of the two studies presented on the previous pages as this has already 
been done extensively in section 2.3 and section 2.4, but rather discuss the 
usefulness of these findings for clinicians within a broader framework. 
4.1 Evaluation of the validity of the current diagnostic criteria for 
primary progressive aphasia 
To a great extent, the results of our separate meta-analyses on nfvPPA, svPPA, and 
lvPPA studies validated the revised diagnostic imaging criteria. Interestingly, the 
results of our meta-analyses across MRI studies even extended the proposed 
imaging criteria by showing additional atrophy in the anterior medial temporal lobe 
(right amygdala and bilaterally hippocampus/parahippocampal gyri) for svPPA and in 
the middle temporal gyrus, superior temporal gyrus, putamen, and precentral gyrus 
for nfvPPA. Furthermore, the results of our meta-analysis on lvPPA showed that the 
angular gyrus might not be as consistently atrophied in these patients as has been 
assumed so far, while the dorsal posterior cingulate gyrus and superior/middle 
temporal gyrus most probably constitute additional diagnostic imaging marker for 
lvPPA. We suggest that these findings should be considered in future revisions of the 
diagnostic criteria for PPA. 
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Another highly interesting finding resulted from the comparison between the results 
of both meta-analyses (one across MRI and one across PET studies) on svPPA. This 
comparison showed that it might be useful, at least for this PPA variant, to define 
separate diagnostic imaging criteria for FDG-PET and MRI scans. Future studies will 
show whether separate imaging criteria for FDG-PET and MRI should be applied 
similarly to nfvPPA and lvPPA. Separate imaging modality-specific diagnostic criteria 
have also already been proposed for other types of dementia (Dubois et al., 2007; 
Schroeter et al., 2014; Schroeter et al., 2008). We suggest that future revisions of the 
diagnostic criteria for PPA should include the current knowledge about separate 
imaging markers for FDG-PET and MRI scans. 
While we evaluated and validated the revised diagnostic imaging criteria, other 
authors evaluated the revised diagnostic clinical criteria for PPA (Harris et al., 2013; 
Mesulam, Wieneke, Thompson, Rogalski, & Weintraub, 2012; Sajjadi, Patterson, 
Arnold, Watson, & Nestor, 2012; Wicklund et al., 2014). In a prospective data-driven 
study, Sajjadi et al. (2012) examined to which extent 46 consecutively recruited 
patients would be classifiable according to the revised clinical diagnostic criteria for 
PPA. Additionally, these authors investigated which linguistic impairments would 
cluster together (and thus form distinct syndromes) using principal factor analysis. In 
this patient cohort, 58.7 % of the patients could be assigned to one of the three 
variants of PPA proposed by Gorno-Tempini et al. (2011), while 41.3 % of the 
patients were classified as mixed PPA because their deficits either extended beyond 
a single PPA variant (i.e., showed also linguistic impairments expected to be spared 
in this syndrome) or they met the diagnostic criteria for more than one variant 
(whithout showing differences in disease duration). The principal factor analysis 
identified two clear syndromes corresponding to the proposed syndromes of svPPA 
and nfvPPA as well as a residual miscellany. Interestingly, impaired sentence 
repetition which has been proposed as a cardinal diagnostic feature for lvPPA 
aligned with the factor corresponding to nfvPPA (Sajjadi et al., 2012). Similarly, 
Wicklund et al. (2014) showed that 31 % of 84 PPA patients were unclassifiable 
according to the current diagnostic criteria (some fulfilled simultaneously the 
diagnostic criteria for more than one PPA variant and some fulfilled the criteria for 
lvPPA except for the core feature of impaired repetition). 
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It has been proposed that some of the problems of unclassifiable patients according 
to the diagnostic criteria of Gorno-Tempini et al. (2011) might be circumvented if 
impaired repetition would be regarded as an ancillary rather than a core feature of 
lvPPA and if the “absence of definite grammar and comprehension impairment” 
would be regarded as a core feature of lvPPA (Mesulam & Weintraub, 2014). 
Mesulam and Weintraub (2014) furthermore proposed that the recognition of a 
“mixed” PPA variant might highly decrease the number of unclassifiable cases 
because some patients already show at very early stages of the disease a 
combination of agrammatism and semantic impairment. It is thus highly probable that 
the diagnostic criteria for PPA will be revised within the next years.  
Changes in consensus diagnostic criteria can have a major impact as has for 
instance been shown for the shift from the previous consensus criteria on PPA 
proposed by Neary et al. (1998) to the current diagnostic criteria for PPA of Gorno-
Tempini et al. (2011). Chare and colleagues showed that the comparison of the 
diagnostic criteria of Neary et al. (1998) and the revised criteria of Gorno-Tempini et 
al. (2011) revealed no changes in the diagnosis of 87 % of the svPPA patients, but 
that 51 % of the nfvPPA patients were reclassified as suffering from lvPPA (Chare et 
al., 2014). These reclassifications of patients were due to several reasons (Mesulam 
& Weintraub, 2014). Altough Neary et al. (1998) did not explicitly claim to cover and 
characterize all possible variants of PPA in their diagnostic criteria, most researchers 
and clinical practicioners used these diagnostic criteria as such (Mesulam & 
Weintraub, 2014). Consequently, lvPPA was not recognized as a distinct syndrome 
and PPA patients with a pathology different from FTLD were previously implicitly 
excluded from the diagnosis of PPA. Furthermore, in the revised diagnostic criteria of 
Gorno-Tempini et al. (2011) impaired repetition is no longer one of the supportive 
criteria for nfvPPA, but is included as a core diagnostic criterium for lvPPA. Anomia, 
which has previously been part of the diagnostic features for nfvPPA (Neary et al., 
1998), is meanwhile attributed to svPPA if it is accompagnied with loss of word 
meaning and to lvPPA if it appears without loss of word meaning (Mesulam & 
Weintraub, 2014). By first diagnosing PPA according to Mesulam (2001) before 
further specifying the concrete variant of PPA, patients whose most prominent 
problem is prosopagnosia and/or an associative agnosia (and would therefore have 
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been classified as svPPA according to the criteria of Neary et al. (1998)) are now 
explicitly excluded from the diagnosis of svPPA (Mesulam & Weintraub, 2014).  
The changes from the diagnostic criteria for PPA proposed by Neary et al. (1998) to 
the current diagnostic criteria for PPA of Gorno-Tempini et al. (2011) lead to a 
relatively large number of reclassified patients (Chare et al., 2014). One might 
wonder how importantly the suggested revisions of the diagnostic criteria of Gorno-
Tempini et al. (2011) might affect the current diagnoses of PPA patients. The 
suggested revisions for future consensus diagnostic criteria concern mostly lvPPA 
(i.e., regard impaired repetition as ancillary feature and the absence of definite 
grammar and comprehension impairment as core features for lvPPA) and the 
recognition of patients showing a combination of agrammatism and semantic 
impairment as distinct “mixed” PPA variant (Mesulam & Weintraub, 2014; Mesulam et 
al., 2014). 
In the following, we will discuss possible implications of future revisions of the 
diagnostic criteria for the validity and informative value of the two imaging studies 
presented in this thesis. As svPPA and nfvPPA are not affected by the recommended 
revisions, we do not expect that future imaging results (after revision of the current 
diagnostic criteria) for svPPA and nfvPPA will differ importantly from the ones 
presented here. For lvPPA on the other hand, we expect larger study samples 
(including lvPPA with and without impaired repetition), which will enhance the 
statistical power of future studies and thus provide more solid results. Sajjadi, 
Patterson, and Nestor (2014) showed that PPA patients that were unclassifiable 
according to the diagnostic criteria of Gorno-Tempini et al. (2011) showed at group-
level atrophy similar to the currently proposed imaging criteria for lvPPA. Therefore, 
we assume that also for lvPPA, the results of future imaging studies (after revision of 
the current diagnostic criteria) will not differ drastically from the ones presented here. 
Note however, that it is not sure yet, whether the diagnostic criteria of Gorno-Tempini 
et al. (2011) will indeed be revised in near future. The assumptions regarding 
imaging results for PPA variants after the revision of the current diagnostic criteria 
are thus purely speculative and need to be substantiated by future studies. 
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4.2 How useful are the current diagnostic imaging criteria for 
clinical routine? 
In the following, we are going to discuss the usefulness of the current diagnostic 
imaging criteria (respectively their quantification via ALE meta-analysis) for clinical 
routine. The comparison of the separate meta-analyses across MRI studies (via 
conjunction and subtraction analyses) showed that the imaging criteria for the PPA 
variants are highly distinct. The conjunction analysis showed a small regional overlap 
in the posterior middle temporal gyrus between nfvPPA and lvPPA, which suggests 
that this region might play an important role in both PPA variants. Nevertheless, as 
this overlap was very small, a high clinical distinctiveness is still guaranteed. At first 
sight, studies comparing PPA patients to healthy controls at group-level thus suggest 
that these imaging markers constitute useful guidelines for clinicians to correctly 
distinguish between PPA variants in clinical routine. 
We used support vector machine classification to investigate statistically how useful 
MRI scans are actually for the individual diagnosis of PPA patients. In order to 
represent the situation in clinical routine as closely as possible, we considered scans 
assessed at initial presentation for each subjet. Our SVM results showed accuracies 
(in the whole brain approach) ranging from 55 % to 97 %. In a second step, we 
investigated whether it would be sufficient to only consider brain regions 
corresponding to the proposed diagnostic imaging criteria (respectively their 
quantification via ALE meta-analysis) or whether additional brain regions should be 
taken into account. Our results showed that for svPPA, focusing only on the 
(quantification of the) proposed diagnostic imaging criteria lead to a perfect 
discrimination (of 100 %) between patients and healthy controls. For nfvPPA and 
lvPPA on the other hand, the SVM classification showed slightly higher accuracies 
when considering the whole brain. For the discrimination between svPPA and 
nfvPPA/lvPPA, both approaches showed similar results. For the discrimination 
between lvPPA and nfvPPA, the ROI approach showed a higher accuracy than the 
whole brain approach. Given that none of the differences between both approaches 
were statistically significant, we consider both approaches as equally valid. Our 
accuracies for SVM classification considering only the (quantification of the) 
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proposed diagnostic imaging criteria were (except for the discrimination between 
lvPPA and nfvPPA) quite high despite the relatively small size of the chosen brain 
regions. These findings thus provide empirical evidence that (except for the 
differential diagnosis between lvPPA and nfvPPA) the proposed supportive imaging 
criteria constitute (not only at group-level, but) also at individual subject level useful 
guidelines for clinicians to correctly diagnose PPA variants in clinical routine. 
Besides providing a sound statistical method to evaluate the discriminative power 
(and thus the usefulness) of single features (e.g., MRI scans) for the correct 
diagnosis of patients in clinical routine, the SVM method has the practical advantage 
that its algorithm (used to classify subjects after the classifier has been trained), can 
be implemented in an imaging software. SVM is a highly sensitive method which 
takes into account early changes in atrophy that cannot easily be perceived by the 
naked eye. Providing such a software might thus ensure the best use of imaging 
scans to support the diagnosis of PPA patients in clinical routine. Before such a 
software can be put on the market, the algorithm needs however to be optimized in 
order to provide classification accuracies of approximatively 100 %. In the following, 
we are going to discuss possible ways to improve the algorithm and thereby the 
accuracy of support vector machine classification for PPA.  
One possibility to improve the accuracy of the SVM classification using MRI might 
consist in further exploring the optimal number and size of brain regions to be taken 
into account (see section 3.4.3). Regarding this our results unveiled matters of a 
rather technical nature. The SVM classification method is highly sensitive and 
therefore takes into account also very early atrophy. Supposed that several regions 
might be affected similarly in the three PPA variants depending upon the current 
stage of the respective disease (e.g., Rogalski et al., 2011) and structural MRI scans 
do not provide any information regarding the temporal dynamic pattern of brain 
atrophy, SVM classification might not always be able to perfectly discriminate 
between PPA variants. In order to address this rather technical issue, it might be 
highly interesting to investigate in future studies, whether considering disease-
specific networks including also very early atrophy and additionally weighting more 
importantly the brain regions that are rather specific for a given PPA variant as 
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compared to the other PPA variants, would increase the accuracy of SVM 
classification significantly.  
Another possibility to improve the accuracy of the SVM classification using MRI might 
consist in including further parameters like for instance additional imaging data (e.g., 
FDG-PET or diffusion tensor imaging) or language test scores (e.g., Dukart et al., 
2011; Wilson et al., 2009; Zhang et al., 2013) or constructing dynamic disease 
models based on longitudinal data. Wilson et al. (2009) showed for instance, that at 
least for the discrimination between svPPA and nfvPPA, adding linguistic variables to 
MRI data improved significantly the accuracy of the SVM classification. In this regard, 
it might be highly interesting to further investigate which standard language tests 
used in clinical routine provide the most promising results. It has for instance been 
proposed that the Repeat and Point Test (Hodges, Martinos, Woollams, Patterson, & 
Adlam, 2008) assessing single word repetition and comprehension might be 
especially useful for the discrimination between svPPA and nfvPPA. Other authors in 
contrast proposed that considering language tests assessing comprehension and 
grammaticality might discriminate best between PPA variants (Mesulam & Weintraub, 
2014; Mesulam et al., 2014). It might thus be of interest to investigate whether these 
assumptions can be empirically supported using SVM classification and to provide a 
good overview for clinicians regarding the informative value of standard language 
tests used in clinical routine. 
Note however that including further parameters like language test scores and 
additional imaging data into SVM classification for PPA is most probably rather of 
scientific interest than of practical benefit in the sense of realistically implementable 
into an imaging software for clinical purposes. This is due to the fact that different 
clinics use partly different standard tests to evaluate language impairments in their 
PPA patients. Furthermore, most clinics are rather in the possession of an MRI 
scanner than of a PET scanner, because of the great expenses of PET and 
invasiveness of the radioactive tracers (e.g., Berns, 1999). Similarly, diffusion tensor 
imaging sequences on MRI scanners are usually run for scientific purposes only and 
not included as standard sequences in clinical routine. 
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4.3 General limitations 
The main limitations of the work presented in this thesis are the relatively small 
number of studies included in the ALE meta-analyses as well as the relatively small 
number of patients included in the SVM study. Small sample sizes in this research 
field are due to the fact that PPA is an orphan disease with an estimated prevalence 
of approximately 1.1-6.0 per 100,000 in the population (Grossman, 2014). Although 
the cooperation between several clinics and research centers within national and 
international consortia has already largely alleviated this problem, the number of 
subjects recruited over a period of several years is still relatively low.  
Another reason for the relatively small sample sizes in cross-sectional studies is that 
it is advisable to include patients at a relatively early stage of the disease, because it 
has been shown in longitudinal studies that with the progression of the disease, the 
language impairments as well as the atrophic networks in the three variants of PPA 
partly converge (Gorno-Tempini et al., 2011; Rogalski et al., 2011). Furthermore, it 
has been shown that there are considerable longitudinal shifts in PPA variant 
classification while the disease progresses (Mesulam et al., 2014). This seems to 
concern especially lvPPA where seven out of 11 patients progressed over time into 
nfvPPA, svPPA, or mixed PPA (Mesulam et al., 2014). Other authors showed that 
these longitudinal shifts are not limited to the diagnosis of PPA variants, but also 
include other FTLD syndromes (Knibb & Hodges, 2005). Whereas svPPA patients 
frequently develop characteristical features of bvFTD, nfvPPA patients often show 
similarities to patients with corticobasal syndrome (Knibb & Hodges, 2005). In order 
to gain new insights into PPA, it is thus necessary to include patients at a relatively 
early or middle stage of the disease and recruit them over a longer period of time. 
4.4 General conclusion 
The aim of the two studies presented in this thesis was to evaluate the validity of the 
new diagnostic imaging criteria for PPA variants using anatomical likelihood 
estimation meta-analysis and to investigate the usefulness of these criteria for the 
individual diagnosis of PPA patients in clinical routine. To a great extent, the results 
of our separate meta-analyses on nfvPPA, svPPA, and lvPPA studies validated and 
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even extended the revised diagnostic imaging criteria. Furthermore, our results 
suggest that at least for svPPA, it might be useful to define separate diagnostic 
imaging criteria for FDG-PET and MRI scans. Our support vector machine 
classification results showed that the accuracies for SVM classification considering 
only the (quantification of the) proposed diagnostic imaging criteria were (except for 
the discrimination between lvPPA and nfvPPA) quite high despite the relatively small 
size of the chosen brain regions. Our findings thus suggest that (except for the 
differential diagnosis between lvPPA and nfvPPA) the proposed supportive imaging 
criteria constitute (not only at group-level, but) also at individual subject level useful 
guidelines to correctly diagnose PPA variants in clinical routine. 
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5.1 German summary 
Primär progrediente Aphasien (PPA) sind neurodegenerative Erkrankungen, die zu 
einer alltagsrelevanten Beeinträchtigung von Sprachfunktionen führen können. Die 
ersten Studien, die zu PPA und ihren Varianten veröffentlicht wurden, berichteten 
Ergebnisse über sehr geringe Stichprobengrößen oder aber waren Fallbeispiele. 
Dies lag daran, dass es sich bei PPA um eine seltene Erkrankung handelt, deren 
Prävalenz auf circa 1.1-6.0 pro 100.000 Personen in der Bevölkerung geschätzt wird 
(Grossman, 2014). Erst der Zusammenschluss von mehreren Studienzentren zu 
nationalen und internationalen Konsortien machte es möglich größere Stichproben 
zu erheben, welche für repräsentative inferenzstatistische Erkenntnisse unabdinglich 
sind. Weitere Ziele solcher Konsortien sind die Verbesserung der Früherkennung der 
Erkrankung, die Erhebung des Krankheitsverlaufs, das Sammeln von 
epidemiologischen Daten, das Aufdecken von möglichen Risikofaktoren, die 
Evaluation von möglichen Therapien, sowie die Etablierung von einheitlichen 
Diagnosekriterien (z.B., Otto et al., 2011; Brun et al., 1994).  
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Während zwei Jahrzehnten wurden die allgemeinen Diagnosekriterien für 
frontotemporale Demenz (Brun et al., 1994; McKhann et al., 2001) herangezogen, 
um Patienten mit PPA zu diagnostizieren. Die anschließende Spezifizierung des 
Subtyps als progressive nichtflüssige Aphasie oder semantische Demenz erfolgte 
nach den Diagnosekriterien von Neary und Kollegen (Neary et al., 1998). Es stellte 
sich jedoch mit der Zeit heraus, dass nicht alle PPA Patienten eindeutig einem der 
beiden Subtypen zugeordnet werden konnten (z.B., Gorno-Tempini et al., 2004), was 
eine Revision der Diagnosekriterien für PPA zur Folge hatte (Gorno-Tempini et al., 
2011). PPA wurde neu definiert als eine neurodegenerative Erkrankung mit 
schleichendem Beginn, welche sich in den ersten zwei Jahren hauptsächlich als 
isolierte, progrediente Sprachstörung (ohne bedeutsame Beeinträchtigung in 
anderen kognitiven Bereichen) bemerkbar macht. PPA umfasst drei Varianten: die 
semantische Variante (svPPA, früher als semantische Demenz bezeichnet), die 
nichtflüssige Variante (nfvPPA, früher als progressive nichtflüssige Aphasie 
bezeichnet), und die logopenische Variante (lvPPA). Das klinische Erscheinungsbild 
der svPPA ist hauptsächlich gekennzeichnet durch Beeinträchtigungen im Benennen 
und im Verständnis von einzelnen Wörtern, zunehmenden Verlust des Wissens um 
die Bedeutung von Wörtern, Oberflächendyslexie und Oberflächendysgraphie. Die 
Diagnose gilt als bildgebungsgestützt, wenn Patienten zusätzlich Atrophie, 
Hypometabolismus oder Hypoperfusion im anterioren Temporallappen aufzeigen. 
Die nfvPPA ist charakterisiert durch eine nichtflüssige Spontansprache mit 
Sprechanstrengung und langen Pausen, Agrammatismus, Sprechapraxie (Störung 
der Initiierung und Exekution der für das Sprechen notwendigen Bewegungsabläufe), 
sowie beeinträchtigtes Verständnis von grammatikalisch komplexen Sätzen. Diese 
Sprachstörung geht häufig mit Schädigungen in links posterioren frontoinsulären 
Gehirnregionen einher. Die lvPPA ist hauptsächlich gekennzeichnet durch 
beeinträchtigten Wortabruf in der Spontansprache und beim Benennen, sowie 
beeinträchtigtes Nachsprechen von längeren Sätzen. Die Diagnose der lvPPA gilt als 
bildgebungsgestützt, wenn die Patienten zusätzlich zu den genannten klinischen 
Symptomen ebenfalls Atrophie, Hypometabolismus oder Hypoperfusion in links 
posterioren perisylvischen oder parietalen Gehirnregionen aufzeigen. 
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In den revidierten Diagnosekriterien für PPA wird den Ergebnissen aus 
Bildgebungsverfahren ein größerer Wert beigemessen, als es in den vorherigen 
Diagnosekriterien der Fall war (Gorno-Tempini et al., 2011 vs. Neary et al., 1998). 
Die neuen bildgebenden Diagnosekriterien wurden jedoch auf Grund einer rein 
qualitativen Evaluation der Literatur vorgeschlagen. Ziel der beiden im Folgenden 
dargestellten Studien war es, die Validität der neuen bildgebenden Diagnosekriterien 
für PPA zu evaluieren (erste Studie) und ihren praktischen Nutzen für die individuelle 
Diagnosestellung von PPA-Patienten im klinischen Alltag zu untersuchen (zweite 
Studie). 
Die erste Studie befasste sich mit der inferenzstatistischen (quantitativen) 
Evaluierung der Validität der neuen bildgebenden Diagnosekriterien für PPA. Zu 
diesem Zweck wurden Metaanalysen über alle verfügbaren MRT und PET Studien 
durchgeführt (Kapitel 2). Ziel war es die in den einzelnen PPA-Varianten konsistent 
(über mehrere Studien hinweg) betroffenen Gehirnregionen auszumachen und mit 
Hilfe von Subtraktions- und Konjunktionsanalysen herauszufinden, wie 
subtypspezifisch oder überlappend diese Regionen zwischen den einzelnen 
Varianten sind. Ein weiteres Ziel bestand darin zu untersuchen, ob die 
vorgeschlagenen bildgebenden Diagnosekriterien gleichermaßen für alle 
Bildgebungsverfahren gelten, oder ob unterschiedliche Diagnosekriterien für MRT 
und PET angewendet werden sollten, wie es bereits für andere Demenzen 
vorgeschlagen wurde (Dubois et al., 2007; Schroeter et al., 2014). Unsere 
systematische Literaturrecherche ergab 22 Studien (15 MRT, sechs FDG-PET, eine 
MRT & FDG-PET) für svPPA, 14 Studien (11 MRT, drei FDG-PET) für nfvPPA, und 
sechs Studien (sechs MRT, null FDG-PET) für lvPPA. Die Ergebnisse unserer 
Metaanalysen bestätigten größtenteils die vorgeschlagenen bildgebenden 
Diagnosekriterien (p < 0.05, False Discovery Rate korrigiert). Interessanterweise 
zeigten unsere Metaanalysen über MRT-Studien zusätzliche bedeutsame 
Gehirnareale für die einzelnen PPA-Varianten auf. So fanden wir zusätzliche 
Atrophie im anterioren medialen Temporallappen (rechte Amygdala und beidseitig 
Hippocampus) für svPPA sowie im mittleren und superioren Gyrus temporalis, 
Putamen und Gyrus praecentralis für nfvPPA. Des Weiteren zeigten unsere 
Ergebnisse zu lvPPA, dass der Gyrus angularis nicht so konsistent in dieser Variante 
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betroffen ist, wie bislang angenommen wurde, während der dorsale posteriore Gyrus 
cinguli sowie der mittlere und superiore Gyrus temporalis möglicherweise weitere 
bildgebende Marker für lvPPA darstellen. Die Ergebnisse der Subtraktions- und 
Konjunktionsanalysen zeigten, dass (bis auf eine kleine regionale Überlappung 
zwischen nfvPPA und lvPPA im posterioren mittleren Gyrus temporalis), die 
betroffenen Regionen in hohem Maße spezifisch für die einzelnen Varianten sind. 
Der Vergleich zwischen beiden Metaanalysen zu svPPA (eine über MRT- und eine 
über PET-Studien) zeigte nur sehr kleine Überlappungen im inferioren und mittleren 
Gyrus temporalis auf. Diese Ergebnisse legen nahe, dass für svPPA, ähnlich wie für 
andere Demenzen (z.B., Dubois et al., 2007), separate bildgebende 
Diagnosekriterien für PET und MRT von Nutzen sein könnten. Zukünftige Studien 
werden zeigen, ob dies ebenfalls für nfvPPA und lvPPA zutrifft. 
Die vorgeschlagenen bildgebenden Diagnosekriterien für PPA scheinen folglich 
(zumindest für die Beurteilung von MRT-Scans) nützliche Richtlinien für Kliniker 
darzustellen. Es besteht jedoch genereller Konsens, dass Studienergebnisse, die auf 
Gruppenvergleichen basieren, nicht unbedingt zur Evaluierung einzelner individueller 
MRT-Scans herangezogen werden können, weil die Sensitivität und Spezifizität von 
Gruppenvergleichen nicht ausreichend sind, um anfängliche Atrophie zu erfassen. 
In der zweiten Studie wollten wir mittels Support Vektor Maschinen (SVM)-
Klassifikation statistisch untersuchen, wie nützlich MRT-Scans allgemein für die 
Diagnosestellung von PPA-Patienten im klinischen Alltag sind (Kapitel 3). Des 
Weiteren wollten wir gezielter untersuchen, ob hierbei die ausschließliche 
Fokussierung auf die vorgeschlagenen bildgebenden Diagnosekriterien (bzw. deren 
Quantifizierung mittels Metaanalysen, welche in der ersten Studie berichtet wurde) 
den diagnostischen Wert von MRT-Scans verbessern würde. Wir verglichen hier 44 
rechtshändige PPA Patienten (16 nfvPPA, 17 svPPA und 11 lvPPA) mit 20 
rechtshändigen gesunden älteren Kontrollen, welche für Stichprobengröße, Alter, 
Geschlecht und Scanning-Parameter gematcht waren. Alle Probanden wurden im 
Rahmen des Deutschen und Italienischen Konsortiums für Frontotemporale 
Lobärdegeneration erhoben (Otto et al., 2011). Die verglichenen Gruppen 
unterschieden sich nicht signifikant in Alter, Geschlecht, Bildungsstand, oder 
Krankheitsdauer. Die Vorhersagegenauigkeit für die Analysen, die das gesamte 
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Gehirn umfassten, variierten für die SVM-Klassifikationen zwischen PPA-Patienten 
und Kontrollen von 91 % für nfvPPA über 95 % für lvPPA zu 97 % für svPPA. Die 
SVM Klassifikation zeigte eine Genauigkeit von 78 % für svPPA versus nfvPPA und 
eine Genauigkeit von 95 % für lvPPA versus svPPA. Für die Unterscheidung 
zwischen lvPPA und nfvPPA zeigte die SVM Klassifikation eine Genauigkeit von 
55 %. Diese Zahlen sind im Einklang mit SVM Studien zu anderen 
neurodegenerativen Erkrankungen (z.B. Alzheimer-Krankheit oder leicht kognitive 
Einschränkung; Davatzikos, Resnick, et al., 2008; Dukart et al., 2011). Um 
herauszufinden ob die Gehirnregionen, die am meisten zur SVM-Klassifikation 
zwischen Patienten und Kontrollen beitragen, den Gehirnregionen entsprechen, die 
am meisten in diesen Patientengruppen atrophisch sind, haben wir zusätzlich 
statistische Gruppenvergleiche zwischen Patienten und gesunden Kontrollen 
gerechnet. Unsere Ergebnisse zeigten, dass die Regionen, die am meisten zur SVM-
Klassifikation zwischen Patienten und Kontrollen beitrugen, in der Tat größtenteils 
den Regionen entsprachen, die in den entsprechenden Patientengruppen atrophisch 
waren. Die ausschließliche Fokussierung auf die (Quantifizierung mittels 
Metaanalysen der) bildgebenden Diagnosekriterien zeigte für svPPA eine höhere 
Vorhersagegenauigkeit auf (100 %) als wenn das gesamte Gehirn berücksichtigt 
wurde (97 %). Die Vorhersagegenauigkeiten für nfvPPA (84 %) und lvPPA (82 %) 
hingegen waren leicht geringer, wenn ausschließlich die bildgebenden 
Diagnosekriterien in Betracht gezogen wurde. Für die Klassifikation zwischen svPPA 
und nfvPPA bzw. lvPPA war die Vorhersagegenauigkeit bei beiden Methoden gleich 
(78 % bzw. 95 %). Für die Klassifikation zwischen lvPPA und nfvPPA war die 
Vorhersagegenauigkeit leicht höher (64 %), wenn ausschließlich auf die 
bildgebenden Diagnosekriterien fokussiert wurde. Zusammengefasst waren die 
Vorhersagegenauigkeiten der SVM-Klassifikationen, wo ausschließlich die 
(Quantifizierung der) bildgebenden Diagnosekriterien berücksichtigt wurde, trotz der 
geringen Größe der betrachteten Regionen, (außer für die Unterscheidung zwischen 
lvPPA und nfvPPA) recht hoch. Unsere Ergebnisse untermauern den praktischen 
Nutzen der vorgeschlagenen bildgebenden Diagnosekriterien für die Beurteilung von 
MRT-Scans zur Diagnosestellung von PPA-Patienten im klinischen Alltag (mit 
Ausnahme für die Differentialdiagnose zwischen lvPPA und nfvPPA). 
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5.2 English summary 
Primary progressive aphasias (PPA) are neurodegenerative diseases that lead to 
profound impairments in language functions. For almost a decade, most studies on 
PPA and its variants were either case reports or single-center studies reporting very 
small sample sizes. Until now, there are no community-based prevalence estimates 
for PPA available, but based on autopsy-proven cases, the prevalence for PPA is 
estimated at approximately 1.1-6.0 per 100,000 in the population (Grossman, 2014). 
PPA is thus an orphan disease. Only the cooperation between several study centers 
within national and international consortia in recent years made it possible to gather 
sufficiently large sample sizes making deductive statistical research in this field 
possible. Further aims of these consortia are to improve disease recognition along 
with its management, evaluate disease progression, collect data on epidemiology, 
find risk factors and early disease markers, evaluate possible therapeutic approaches 
as well as to discuss and establish standard diagnostic criteria (e.g., Otto et al., 2011; 
Brun et al., 1994). 
For two decades, researchers and clinicians have been using the diagnostic criteria 
for frontotemporal dementia (Brun et al., 1994; McKhann et al., 2001) to generally 
diagnose a patient as suffering from PPA and the criteria of Neary et al. (1998) to 
further specify the diagnosis as progressive nonfluent aphasia or semantic dementia. 
However, there were a number of PPA cases that could not be classified according 
to the criteria of Neary and colleagues (Gorno-Tempini et al., 2004; Grossman & Ash, 
2004; Neary et al., 1998), which led to a revision of the diagnostic criteria for PPA 
(Gorno-Tempini et al., 2011). PPA has been redefined as a neurodegenerative 
disease with insidious onset mainly characterized by a language dysfunction that 
remains isolated for at least two years without significant impairment in other 
cognitive domains. PPA subsumes three gradually progressive language disorders, 
namely the semantic variant PPA (svPPA, formerly also known as semantic 
dementia), nonfluent variant PPA (nfvPPA, formerly also known as progressive 
nonfluent aphasia), and the logopenic variant PPA (lvPPA). SvPPA is clinically 
mainly characterized by impairments in confrontation naming, single-word 
comprehension, and object-knowledge, as well as surface dyslexia or dysgraphia. 
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The imaging supported diagnosis of svPPA is given when patients additionally show 
atrophy and/or hypoperfusion/-metabolism in the anterior (ventral and lateral) 
temporal lobe. Patients suffering from nfvPPA show predominantly agrammatism, 
effortful halting speech with inconsistent speech sound errors and distortions (apraxia 
of speech), as well as impaired comprehension of syntactically complex sentences. 
These language deteriorations are often conjoined with atrophy or hypoperfusion/-
metabolism in left posterior fronto-insular regions (e.g., inferior frontal gyrus, insula, 
premotor, and supplementary motor areas). LvPPA is characterized by impaired 
single-word retrieval in spontaneous speech and naming as well as impaired 
repetition of sentences. The imaging supported diagnosis of lvPPA is given when 
patients additionally show atrophy and/or hypoperfusion/-metabolism in left posterior 
perisylvian or parietal areas (e.g., posterior parietal, supramarginal, and angular gyri). 
In the revised diagnostic criteria for PPA, more importance is attributed to the 
diagnostic assessment of imaging scans as has been the case in previous diagnostic 
criteria (Neary et al., 1998). The diagnostic imaging criteria were however proposed 
based on a qualitative evaluation of the literature and have not been validated so far. 
The aim of the two studies presented in this thesis was to evaluate the validity of the 
new diagnostic imaging criteria for PPA (first study) and to investigate the usefulness 
of the diagnostic imaging criteria for the individual diagnosis of PPA patients in 
clinical routine (second study).  
The aim of the first study was to validate the proposed diagnostic imaging criteria for 
PPA at a deductive statistical level. Therefore, we quantitatively evaluated all 
currently available PET and MRI studies using anatomical likelihood estimate meta-
analyses (chapter two). Our objective was to identify the neural networks affected in 
the three PPA variants and examine their regional specificity in subtraction and 
conjunction analyses identifying specific and overlapping networks, respectively. A 
further objective was to investigate whether the proposed imaging criteria would 
apply similarly to PET and MRI scans or whether separate, imaging modality-specific 
imaging criteria should be applied for PPA as has been suggested for other types of 
dementia (Dubois et al., 2007; Schroeter et al., 2014). Our systematic literature 
search yielded 22 studies (15 MRI, six FDG-PET, one MRI & FDG-PET) for svPPA, 
14 studies (11 MRI, three FDG-PET) for nfvPPA, and six studies (six MRI, zero FDG-
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PET) for lvPPA. Analyses were conducted using a false discovery rate corrected 
threshold of p < 0.05. To a great extent, the results of our separate meta-analyses on 
nfvPPA, svPPA, and lvPPA studies validated the revised diagnostic imaging criteria. 
Interestingly, our meta-analytic results across MRI studies even extended the 
proposed imaging criteria by showing additional atrophy in the anterior medial 
temporal lobe (right amygdala and bilaterally hippocampus/parahippocampal gyri) for 
svPPA and in the middle temporal gyrus, superior temporal gyrus, putamen, and 
precentral gyrus for nfvPPA. Furthermore, the results of our meta-analysis on lvPPA 
showed that the angular gyrus might not be as consistently atrophied in these 
patients as has been assumed so far, while the dorsal posterior cingulate gyrus and 
superior/middle temporal gyrus most probably constitute additional diagnostic 
imaging markers for lvPPA. The conjunction and subtraction analyses between the 
separate meta-analyses on PPA variants across MRI studies showed that except for 
a very small regional overlap in the posterior middle temporal gyrus between nfvPPA 
and lvPPA, the neural networks affected in the three PPA variants were highly 
distinct. The comparison between the results of both meta-analyses (one across MRI 
and one across PET studies) on svPPA showed only small conjunctions in inferior 
and middle temporal gyrus, which suggest that it might be useful to define separate 
diagnostic imaging criteria for FDG-PET and MRI. Future studies will show whether 
separate imaging modality-specific criteria apply similarly to nfvPPA and lvPPA. 
At first sight, these results thus suggest that the current imaging criteria indeed 
constitute useful supportive guidelines for clinicians to correctly distinguish between 
PPA variants in clinical routine. There is however a general consensus that the 
results of group-level statistics might not be applicable to individual scans, because 
their sensitivity and specificity at early stages of brain pathology is insufficient for the 
prediction of the status of individual scans (Davatzikos, Resnick, et al., 2008; Fan et 
al., 2008; Wilson et al., 2009).  
In the second study presented in this thesis, we therefore aimed at investigating 
statistically how useful MRI scans are for the individual diagnosis of PPA patients 
using support vector machine (SVM) classification. Furthermore, we raised the 
question whether focusing exclusively on the diagnostic imaging criteria (respectively 
their quantification via anatomical likelihood estimate meta-analyses presented in the 
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first study) would improve the diagnostic value of MRI scans for the individual 
diagnosis. We compared 44 right-handed patients suffering from a variant of PPA (16 
nfvPPA, 17 svPPA, and 11 lvPPA) with 20 right-handed healthy controls that were 
matched as closely as possible for sample size, age, gender, and scanning 
parameters. All data were acquired within the German and Italian Consortium for 
FTLD (Otto et al., 2011). No pair of groups differed significantly in age, gender, 
education, or disease duration (if applicable). Accuracies for the whole brain 
approach in SVM classification between patients and healthy controls ranged from 
91 % for nfvPPA over 95 % for lvPPA to 97 % for svPPA. The SVM classification of 
svPPA vs. nfvPPA showed an accuracy of 78 %. The SVM classification for lvPPA 
vs. svPPA showed an accuracy of 95 % and the SVM classification for lvPPA vs. 
nfvPPA showed an accuracy of 55 %. These numbers are in line with previously 
reported accuracies ranging from 58-100 % in studies on neurodegenerative 
diseases as Alzheimer’s disease and mild cognitive impairment (e.g., Davatzikos, 
Resnick, et al., 2008; Dukart et al., 2011; Klöppel, Stonnington, Barnes, et al., 2008). 
In order to reveal whether the regions that contributed the most to the whole brain 
SVM classification of the three variants of PPA corresponded to the regions that were 
especially atrophied in the respective variants, we additionally conducted statistical 
group-level comparisons between patients and healthy controls. Brain regions that 
were most consistently atrophied in svPPA and lvPPA indeed also contributed the 
most to the SVM classification of these patients. For nfvPPA, on the other hand, 
brain regions that contributed the most to the SVM classification as patients were not 
constrained to the regions that were atrophied in our nfvPPA patients, but also 
encompassed very similar regions in the contralateral hemisphere. A possible 
explanation for the importance of the additional brain regions in the right hemisphere 
might be that they were affected to a lesser extent (and thus not significant in the 
group-level comparison) and that SVM classification as a more sensitive method 
already took into account early atrophy in these regions. For the discrimination 
between svPPA and nfvPPA, the regions that contributed to the SVM classification 
as svPPA patients corresponded to the regions that were most consistently atrophied 
in these patients, while the regions that contributed to the classification as nfvPPA 
were rather spread. Our results showed that for svPPA, focusing only on the 
 5.Summary 
76 
 
(quantification using anatomical likelihood estimate meta-analyses of the) diagnostic 
imaging criteria for PPA showed a higher accuracy (100 %) than the whole brain 
approach (94 %). The accuracy for nfvPPA (84 %) and lvPPA (82 %) was slightly 
lower when focusing only on the (quantification of the) diagnostic imaging criteria as 
compared to the whole brain approach. For svPPA versus nfvPPA (78 %) as well as 
for svPPA versus lvPPA patients (95 %), the accuracy remained unchanged. For 
lvPPA versus nfvPPA, the accuracy was slightly higher when focusing only on the 
(quantification of the) diagnostic imaging criteria (64 %). All in all, the accuracies for 
SVM classification considering only the (quantification of the) proposed diagnostic 
imaging criteria were (except for the discrimination between lvPPA and nfvPPA) quite 
high despite the relatively small size of the chosen brain regions. These findings 
suggest that (except for the differential diagnosis between lvPPA and nfvPPA) the 
diagnostic imaging criteria constitute (not only at group-level, but) also at individual 
level useful guidelines for clinicians to correctly diagnose PPA variants in clinical 
routine. 
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7 Appendix  
7.1 Supplementary material  
7.1.A Supplementary material for “Validating New Diagnostic Imaging Criteria 
for Primary Progressive Aphasia via ALE Meta-analyses” 
Supplementary Table A.1 
Overview of the studies included in the separate meta-analyses on semantic variant PPA, nonfluent 
variant PPA, and logopenic variant PPA 
Study 
 
    N Diagnostic criteria      Age          Disease duration    MMSE    
SvPPA MRI      
Adlam et al. (2006) 7 svPPA Gorno-Tempini et al. 
(2004) 
62.8 (57-72) n.a. 26.0 (23-29) 
 12 HC  65.0 (55-75)  28.8 (27-30) 
Agosta et al. (2012) 7 svPPA 
27 HC 
Gorno-Tempini et al. 
(2011) 
71.5 ± 6.5 5.6 ± 1.5 20.4 ± 8.6 
  68.9 ± 5.9   
Boxer et al. (2003) 11 svPPA Neary et al. (1998) 66.2 ± 9.8 n.a. 21.7 ± 7.1 
 15 HC  65.1 ± 8.3  29.5 ± 0.5 
Brambati et al. (2009) 13 svPPA Neary et al. (1998) 62.0 ± 6.3 3.2 ± 1.1 22.0 ± 6.9 
 6 svPPA  63.1 ± 6.3 5.7 ± 3.7 27.0 ± 2.6 
 25 HC  64.8 ± 6.9  29.6 ± 0.8 
Desgranges et al.  10 svPPA Neary et al. (1998) 65.7 ± 8.6 3.3 ± 2.5 24.2 ± 3.08 
(2007) 17 HC  65.8 ± 7.4  n.a. 
Gorno-Tempini et al.  10 svPPA Neary et al. (1998) 63.0 ± 5.8 4.0 ± 1.2 23.1 ± 6.5 
(2004) 64 HC Gorno-Tempini et al. 
(2004) 
68.2 (56-81)  n.a. 
Grossman et al. 
(2004) 
8 svPPA McKhann et al. (2001) 65.5 ± 13 3.46 ±  3.27 23.8 ± 4.6 
 12 HC Neary et al. (1998) 68.5 ± 9.4  n.a. 
  The L&MG (1994)    
Halpern et al. (2004) 3 svPPA McKhann et al. (2001) 67.73 ± 8.75 4.72 ± 1.73 22.87 ± 3.72 
 12 HC Neary et al. (1998) matched   
  The L&MG (1994)    
      
Josephs et al. (2008) 15 svPPA Neary et al. (1998) 64 (54-74) 3.7´(0.7-0.5) 21 (9-28) 
 12 svPPA  64 (49-77) 3.4 (1.2-5.4) 26 (18-29) 
 27 HC  64 (53-75)  29 (27-30) 
Josephs et al. (2009) 8 svPPA Neary et al. (1998) 68 (56-73) n.a. 26 (20-27) 
 30 HC  matched   
Mummery et al. 
(2000) 
6 svPPA Neary et al. (1998) 60.5 (58-65) n.a. n.a. 
 14 HC  62 (60–65)   
Noppeney et al. 
(2007) 
6 svPPA The L&MG (1994) 61.17 (59-
66) 
n.a. 21.83 
 60 HC     
 
Pereira et al. (2009) 8 svPPA Neary et al. (1998) 62.9 ± 6.40 5.0 ± 2.52 21.0 ± 5.86 
 25 HC  63.8 ± 7.20  29.3 ± 0.84 
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Schwindt et al. (2011) 9 svPPA Neary et al. (1998) 67.6 ±7.6 6.4 ± 2.7 19.9 ± 8.4 
 16 HC Gorno-Tempini et al. 
(2011) 
   
Wilson et al. (2009) 5 svPPA Neary et al. (1998) 61.4 ± 4.8 5.9 ± 1.7 24.2 ± 4.8 
 48 HC  61.5 ± 10.3  n.a. 
Wilson et al. (2010) 25 svPPA Neary et al. (1998) 66.7 ± 6 8.9 ± 3.1 22 ± 6.2 
 10 HC  68.5 ± 5.9  29.5 ± 0.5 
      
SvPPA PET      
Desgranges et al.  10 svPPA Neary et al. (1998) 65.7 ± 8.6 3.3 ± 2.5 24.2 ± 3.08 
(2007) 17 HC  65.8 ± 7.4  n.a. 
Diehl et al. (2004) 9 svPPA The L&MG (1994) 62.1 ± 3.6 4 ± 4.05 25.00 ± 3.55 
 15 HC  61.8 ± 9.1  n.a. 
Diehl-Schmid et al.  8 svPPA Neary et al. (1998) 62.8 ± 3.8 4.38 ± 3.34 25.1 ± 4.8 
(2006) 15 HC  61.8 ± 9.1 4.4 ± 3.1 n.a. 
Drzezga et al. (2008) 8 svPPA Neary et al. (1998) 66.4± 4.9 n.a. 19.9 + 6.7 
 26 HC  65.4 ± 10.5  n.a. 
Nestor et al. (2006) 9 svPPA Neary et al. (1998) 63.4 ± 7.0 3.6 ± 2.1 25.8 ± 3.3 
 14 HC  61.4 ± 6.9  29.8 ± 0.4 
Raczka et al. (2010) 7 svPPA The L&MG (1994) 64.6 ± 3.0 n.a. 20.0 ± 10.0 
 9 HC Neary et al. (1998) 59.3 ± 8.0  n.a. 
Suh et al. (2010) 6 svPPA Neary et al. (1998) 65.0 ± 9.6 n.a. 21.7 ± 3.7 
 13 HC  71.5 ± 2.0  n.a. 
      
      
      
NfvPPA MRI      
Agosta et al. (2011) 9 nfvPPA Gorno-Tempini et al. 
(2011) 
67.7 ± 5.1 2.0 ± 1.0 20.0 ± 7.0 
Gorno-Tempini et al.  11 nfvPPA Neary et al. (1998) 67.9 ± 8.1 4.4 ± 2.5 26.0 ± 3.4 
(2004) 64 HC Gorno-Tempini et al. 
(2004) 
68.2 (56-81)   
Gorno-Tempini et al.  6 nfvPPA Gorno-Tempini et al. 
(2004) 
69.2 ± 8.2 4.5 ± 2.1 26.8 ± 1.3 
(2006) 5 nfvPPA  62.4 ± 9.5 4.3 ± 2.1 29.2 ± 0.8 
 40 HC  65.1   
Grossman et al. 
(2004) 
7 nfvPPA McKhann et al. (2001) 68.9 ± 11.4 3.25 ± 1.88 21.9 ± 7.1 
 12 HC Neary et al. (1998) 68.5 ± 9.4   
  The L&MG (1994)    
Hu et al. (2010) 11 nfvPPA Neary et al. (1998) 65.16 ± 0.45 3.11.± 1.66 22.58 ± 
 24 HC McKhann et al. (2001) 65.2 ±8.6  5.78 
  Gorno-Tempini et al. 
(2008) 
   
Josephs et al. (2006) 3 nfvPPA Neary et al. (1998) 63.3 ± 7.1 5.7 ± 1.2 n.a. 
 12 HC  matched   
Nestor et al. (2003) 7 nfvPPA Neary et al. (1998) 68.8 ± 7.8 3.4 ± 1.4 22.1 ± 7.0 
 10 HC  65.9 ± 6.1  29.8 ± 0.4 
Pereira et al. (2009) 3 nfvPPA Neary et al. (1998) 68.33 ± 9.02 3.3 ± 2.52 17.7 ± 4.51 
 25 HC  63.8 ± 7.20  29.3 ± 0.84 
Schwindt et al. (2011) 9 nfvPPA 
16 HC 
Neary et al. (1998) 65.2 ±10.8 
70.1 ± 8.7 
4.1 ± 2.0 20.0 ± 10.1 
 Gorno-Tempini et al. 
(2011) 
  
Wilson et al. (2010) 14 nfvPPA Gorno-Tempini et al. 
(2011) 
67.8 ± 8.1 6.3 ± 1.9 25.9 ± 4.1 
 10 HC  68.5 ± 5.9  29.5 ± 0.5 
Zahn et al. (2005) 5 nfvPPA 
10 HC 
Neary et al. (1998) 65.0 ± 7.4 
65.8 ± 7.8 
n.a. 23.0 ± 5.3 
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NfvPPA PET      
Nestor et al. (2003)   7 nfvPPA Neary et al. (1998) 68.8 ± 7.8 3.4 ± 1.4 22.1 ± 7.0 
 10 HC  65.9 ± 6.1  29.8 ± 0.4 
Perneczky et al. 
(2007) 
11 nfvPPA 
16 HC 
Neary et al. (1998) 69.91 ± 8.10 
67.88 ± 9.99 
3.20 ± 2.04 18.91 ± .76 
30.00 ± 0.00 
Zahn et al. (2005)   5 nfvPPA Neary et al. (1998) 65.0 ± 7.4 n.a 23.0 ± 5.3 
 12 HC  48.0 ± 16.0  n.a. 
      
LvPPA MRI      
Agosta et al. (2011)   4 lvPPA 
27 HC 
Gorno-Tempini et al. 
(2011) 
66.8 ± 6.4 
68.9 ± 5.9 
2.5 ± 0.7 19.5 ± 5.2 
  
Gorno-Tempini et al.  10 lvPPA Neary et al. (1998) 72.0 ± 8.5 4.5 ± 0.8 22.2 ± 4.6 
(2004) 64 HC Gorno-Tempini et al. 
(2004) 
68.2(56–81)   
Gorno-Tempini et al.  
(2008) 
  4 lvPPA 
40 HC 
Gorno-Tempini et al. 
(2004) 
58.75 ± 2.9 
matched 
3 ± 0 21.5 ± 2.87 
   
Hu et al. (2010) 12 lvPPA Neary et al. (1998) 62.74 ± 8.36 3.05 ± 1.9 22.28 ± 7.73 
 24 HC McKhann et al. (2001) 65.2 ±8.6   
  Gorno-Tempini et al. 
(2008) 
   
Migliaccio et al. 
(2009) 
10 lvPPA 
65 HC 
Gorno-Tempini et al. 
(2004) 
63.5 ± 7.2 
60.7 ± 10.1 
3.3 ± 2.1 20.5 ± 4.4 
28 ± 1.5 
   
Wilson et al. (2010) 11 lvPPA 
10 HC 
Gorno-Tempini et al. 
(2011) 
63.5 ± 7.3 
68.5 ± 5.9 
6 ± 2.8 22.3 ± 6.2 
29.5 ± 0.5 
   
Note. HC healthy controls, lvPPA logopenic variant PPA, L&MG Lund and Manchester groups, MMSE 
Mini-Mental State Examination, MRI magnetic resonance imaging, nfvPPA nonfluent variant PPA, n.a. 
not available, N number of subjects, PET positron emission tomography, svPPA semantic variant 
PPA. Age (years), disease duration (years), and MMSE are indicated either as mean (range) or mean 
± standard deviation as reported in the respective single studies. The diagnostic criteria were taken as 
they were from the original studies.  
 7. Appendix 
92 
 
Supplementary Table A.2 
Results of the subtraction analyses between meta-analyses on semantic variant PPA (magnetic 
resonance imaging studies versus positron emission tomography studies) and between meta-analyses 
on different variants of primary progressive aphasia (magnetic resonance imaging studies) 
Note. ALE anatomical likelihood estimation, BAs Brodmann areas, FDG-PET fluorodeoxyglucose 
positron emission tomography, Lat. lateralization, L left, lvPPA logopenic variant PPA, MNI Montreal 
Neurological Institute, MRI magnetic resonance imaging, nfvPPA nonfluent variant PPA, R right, 
svPPA semantic variant PPA.  
 
 
Region Lat. BAs 
    MNI 
coordinates 
    x        y      z 
Volume 
     (mm3) 
ALE-
value 
SvPPA MRI > PET         
Inferior, middle, & superior 
temporal gyri/fusiform gyrus/ 
R 28/34/38  27 -0 -21 6592 3.2389 
hippocampus/parahippocampal 
gyrus/amygdala 
        
Hippocampus/parahippocampal 
gyrus/amygdala 
L 28/34  -26 -4 -20 3504 2.9478 
         
SvPPA PET > MRI         
Thalamus L   -7 -18 15 280 1.8807 
Inferior temporal gyrus /fusiform 
gyrus 
L 20  -48 -22 -32 240 2.2903 
         
SvPPA > nfvPPA & lvPPA         
Inferior, middle, & superior 
temporal gyri/fusiform gyrus/ 
hippocampus/parahippocampal 
gyrus/amygdala 
R 28/34/38/  27 -1 -1 8952 3.7190 
Inferior temporal 
gyrus/hippocampus/parahippoca
mpal gyrus 
L 20/28  -28 -4 -7 5304 3.7190 
Fusiform & parahippocampal gyri L 20/36  -38 -30 -22 1432 3.1559 
Superior temporal gyrus L 38  -44 15 -3 912 1.9881 
Inferior temporal gyrus L 21/38  -42 -2 -44 664 2.5366 
Middle temporal gyrus R 21  48 10 -44 472 2.9112 
Superior temporal gyrus L 38  -36 14 -42 248 2.1200 
         
NfvPPA > svPPA & lvPPA         
Insula/inferior frontal gyrus L 6  -42 22 2 944 3.2388 
Middle frontal gyrus  L 13/44  -35 42 21 448 2.2903 
Superior frontal gyrus L   -21 -7 62 448 2.9478 
Insula L 13  -40 4 49 424 1.8694 
Putamen L 10  -24 10 -4 416 2.8208 
Insula L 9  -52 14 18 368 1.9172 
         
LvPPA > svPPA & nfvPPA         
Middle & superior temporal gyri L 13/21/22  -55 -39 9 3352 3.7190 
Supramarginal gyrus L 39/40  -55 -52 33 2184 3.5401 
Temporal gyrus L 21/22  -65 -22 1 1192 3.7190 
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Supplementary Figure A: PRISMA 2009 Flow Diagram of the study selection for the meta-analyses on 
primary progressive aphasia 
Records identified through database 
searching 
(n = 658) 
Additional records identified through 
other sources 
(n = 0) 
Records after duplicates removed 
(n = 658) 
 
Records screened based 
on title and abstract 
(n = 180) 
Full-text articles excluded 
(n = 150) 
 
42 reviews/case reports 
31 no whole brain 
coordinates 
(region of interest, 
correlation between 
atrophy and 
psychological functions) 
24 no healthy controls 
41 PPA without further 
specification  
12 other methods (fMRI, 
cortical thickness) 
Id
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Full-text articles assessed 
for eligibility 
(n = 180) 
Studies included in 
qualitative data synthesis 
(n = 30) 
Records excluded 
(n = 478) 
Studies included in 
quantitative data synthesis 
(meta-analysis) (n = 30) 
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7.1.B Supplementary material for “Validating New Diagnostic Imaging Criteria 
for Primary Progressive Aphasia via ALE Meta-analyses” 
Supplementary Table B.1  
Demographic and clinical characteristics of the investigated subject groups 
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Supplementay Table B.2 
Voxel-based morphometry results for the three variants of PPA as compared to healthy controls 
Note. Lat. Lateralization, MNI Montreal Neurological Institute, PPA primary progressive aphasia. 
 
 
region Lat. MNI coordinates    p-value T-
value x y z 
Nonfluent variant PPA < healthy controls       
Inferior, middle, and superior temporal gyri/parahippocampal 
gyrus/hippocampus/amygdala/orbital 
gyri/putamen/insula/inferior frontal gyrus/angular  
gyrus/supramarginal gyrus 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
L -42 -16 10 < 0.0001 6.92 
 -42 -12 18  6.14 
 -18 -15 -12  
6.09 
 
 
Inferior frontal gyrus/precentral gyrus/middle frontal gyrus 
L -52 8 31 < 0.0001 5.86
 -28 5 52  5.43 
 -30 -10 63  4.68 
Middle frontal gyrus/superior frontal gyrus L -26 48 21 < 0.0001 5.82 
 -6 63 12  5.80 
 -21 41 24  5.61 
Inferior frontal gyrus, pars orbitalis/insula  34 24 9 0.036 4.82 
Semantic variant PPA < healthy controls       
Inferior, middle, and superior temporal gyri/fusiform 
gyrus/parahippocampal gyrus/hippocampus/amgdala/gyrus 
rectus/orbital gyrus/insula /inferior frontal gyrus/cingulate 
gyrus/putamen/caudate nucleus/angular gyrus 
L/R -27 2 -36 < 0.0001 13.98 
 -15 3 -45  11.98 
 -44 -15 -45  11.58 
Superior frontal gyrus/cingulate gyrus L -3 15 34 0.009 4.65 
 -3 2 42  4.30 
 -3 44 19  4.30 
Logopenic variant PPA < healthy controls       
Inferior, middle, and superior temporal gyri/fusiform 
gyrus/middle occipital gyrus/gyrus rectus/orbital 
gyrus/putamen/caudate nucleus/thalamus/insula/inferior 
frontal gyrus, pars orbitalis/middle frontal gyrus/superior 
frontal gyrus/cingulate gyrus/precentral gyrus/postcentral 
gyrus/angular gyrus/precuneus/supramarginal gyrus 
L -32 26 9 < 0.0001 10.29 
 -46 -52 4  8.41 
 -30 3 52  7.72 
      
Middle and superior temporal gyri R 69 -40 9 < 0.0001 5.75 
 54 -25 -11  5.36 
 50 -27 1  5.25 
Cingulate gyrus/precuneus 
 
L -12 -54 27 0.040 6.08 
 -15 -49 42  
 
 
5.14 
Semantic variant PPA < nonfluent variant PPA 
 
      
Inferior, middle, and superior temporal gyri/fusiform 
gyrus/parahippocampal gyrus/hippocampus/amgydala/insula 
L -16 3 -44 < 0.0001 7.99 
 -33 -25 -30  7.92 
 -22 12 -32  7.22 
Inferior, middle, and superior temporal gyri/fusiform 
gyrus/parahippocampal gyrus/hippocampus/amgydala/insula 
R 42 -4 -29 < 0.0001 6.50 
 36 4 -32  6.16 
  45 27 -33  5.93 
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Supplementary Table B.3 
Positive and negative predictive values for the support vector machine classification results between 
the three variants of primary progressive aphasia and healthy controls as well as between PPA 
variants 
 
 Positive predictive value Negative predictive value 
nfvPPA versus healthy controls       
regions-of-interest   87 %   82 %  
whole brain  93 %   88 %  
svPPA versus healthy controls       
regions-of-interest   100 %   100 %  
whole brain  100 %   94 %  
lvPPA versus healthy controls       
regions-of-interest   82 %   82 %  
whole brain  100 %   92 %  
svPPA versus nfvPPA       
regions-of-interest   76 %   80 %  
whole brain  76 %   80 %  
lvPPA versus svPPA       
regions-of-interest   92 %   100 %  
whole brain  92 %   100 %  
lvPPA versus nfvPPA       
regions-of-interest   62 %   67 %  
whole brain     54 %    56 %  
Note. LvPPA logopenic variant PPA, nfvPPA nonfluent/agrammatic variant PPA, PPA primary 
progressive aphasia, svPPA semantic variant PPA. Positive predictive value=true positives (patients 
that were correctly classified as patients)/all subjects that were (correctly or incorrectly) classified as 
patients. Negative predictive value=true negatives (healthy controls that were correctly classified as 
healthy controls)/all subjects that were (correctly or incorrectly) classified as healthy controls. For 
svPPA versus nfvPPA, the positive predictive value refers to the number of correctly classified svPPA 
patients/all patients that were (correctly or incorrectly) classified as svPPA patients, while the negative 
predictive value refers to the number of correctly classified nfvPPA patients/all patients that were 
(correctly or incorrectly) classified as nfvPPA patients. For lvPPA versus svPPA/nfvPPA, the positive 
predictive value refers to the number of correctly classified lvPPA patients/all patients that were 
(correctly or incorrectly) classified as lvPPA patients, while the negative predictive value refers to the 
number of correctly classified svPPA/nfvPPA patients/all patients that were (correctly or incorrectly) 
classified as svPPA/nfvPPA patients. 
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